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SUMMARY
Down's syndrome is caused by the presence in an 
individual of three copies of gene loci in a critical region 
in the long arm of chromosome 21. Usually a complete extra 
copy of chromosome 21 is present (trisomy) and at birth this 
has an overall frequency of 1 in 700. The most important 
clinical effect is severe mental retardation, and Down's 
syndrome represents the most commonly identified cause of 
human mental handicap. The phenotype also includes dysmorphic 
features, malformations of major organs, an increased risk of 
leukaemia and presenile Alzheimer-type dementia.
Older cytogenetic studies of chromosomal 
heteromorphisms have shown that in 80% of cases the 
additional chromosome in trisomy 21 is of maternal origin. 
Surprisingly this proportion did not seem to be increased in 
older mothers (over 35 years) who are known to have an 
increased frequency of Down's syndrome offspring. The 
cytogenetic studies were, however, uninformative in many 
cases.
The main aim of the present project was to isolate 
polymorphic DNA probes from chromosome 21 which could be used 
to study nondisjunction in Down's syndrome families and to 
construct a genetic linkage map of chromosome 21. Cloned 
sequences derived from the critical region were to be 
analysed for expression in an attempt to identify expressed 
genes of pathogenic importance.
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Two chromosome 21-specific recombinant libraries were 
screened and of 486 bacteriophage clones initially selected, 
29 recombinants were further analysed. Fourteen of these 
were shown to contain highly repetitive DNA sequences and 
were not studied further. The remaining 15 clones contained 
single- or low-copy number sequences and these were 
regionally mapped on chromosome 21 using a panel of somatic 
cell hybrids. Five of the single-copy sequences (JG21/D21S86, 
JG62/P21S90, JG72/P21S92, JG90/D21S95, JG99/D21S97) mapped in 
the 21q21-q22.1 region. A further six (JG12/D21S85, 
JG22/P21S87, JG24/P21S88, JG63/D21S91, JG81/D21S94,
JG108/D21S99) were localised in the 21q22.1-qter region and 
one (JG77/D21S93) in the 21q22.l-q22.2 region. Probe JG373 
(D21S101) was mapped in the distal part of band 21q22.3.
The remaining two DNA sequences (JG51 and JG73) are 
mildly repetitive and were mapped to the pericentromeric 
region of chromosome 21. Although these clones were isolated 
separately from the same recombinant library and have 
different human insert sizes, they appear to detect homology 
with the same series of sequences in the human genome, which 
are present on chromosome 21 and on other chromosomes. The
results obtained with these two probes suggest that they are
part of the alphoid repeat family, members of which are 
present at the centromere of every human chromosome.
Eight of the probes isolated in the present project
were tested with a total of 25 restriction endonucleases and 
five restriction fragment length polymorphisms (RFLPs) were
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discovered : JG77/D21S93 detects an Msp I polymorphism, with 
alleles of 6kb and 3kb, of frequencies 0.67 and 0.33, 
respectively; JG81/D21S94 detects two RFLPs, with the enzymes 
Pvu II and Eco RV - the allele sizes and frequencies (in 
parenthesis) for these two RFLPs are 8.5kb(0.83)/8kb(0.17) 
for Pvu II and 5kb(0.88)/4.5kb(0.12) for Eco RV; JG90/D21S95 
detects an RFLP with the enzyme Nde II, with allele 
sizes/frequencies of 2.2kb(0.7) and 1.8kb(0.3); the other 
RFLP is detected by JG99/D21S97 with the enzyme Pst I and has 
7kb(0.16) and 6.6kb(0.84) alleles.
The Msp I RFLP detected by JG77/D21S93 was used in 
conjunction with 4 other previously described polymorphic 
chromosome 21 probes to analyse the origin of nondisjunction 
in a total of 33 Down's syndrome families. Cytogenetic 
analysis by Q-banding was also used in some of these 
families. The parental origin of the additional chromosome 
was determined in 12 cases (36%) - in 9 of these (75%) the 
additional chromosome was of maternal origin, while in the 
other 3 (25%) it was derived from the father. These 
proportions are in agreement with those obtained previously 
from studies of cytogenetic heteromorphisms. The meiotic 
stage of the nondisjunctional event was defined in 7 families 
using RFLPs as follows : maternal 1 - 2  cases, maternal II - 
3 cases, paternal II - 2 cases, cytogenetic analysis was
informative in 3 of the 5 families studied and confirmed the 
results obtained with DNA markers in each case. In two of the 
families it also allowed localisation of nondisjunction to
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the first maternal meiotic division, bringing the total 
number of such cases to 4.
In one family results obtained with the 
JG77(P21S93)/Msp I polymorphism localised nondisjunction to 
the second maternal meiosis. Results obtained with the 
D21k9(D21S13) marker and Q-banding heteromorphisms, both of 
which are more closely linked to the centromere, showed 
nondisjunction to have occurred at the first maternal meiotic 
division. These latter results are more reliable and it can 
be stated that in this family crossing-over occurred between 
the d21k9(P21S13) and JG77(D21S93) markers in the mother, 
prior to nondisjunction at the first meiotic division. This 
is consistent with emerging data obtained from other workers 
and shows that reduced recombination between chromosome 21 
homologues is not the major cause of trisomy in Down's 
syndrome, as had been suggested. The possible effects of 
recombination on the interpretation of RFLP data are also 
clearly demonstrated in this case, emphasising the importance 
of using pericentromeric markers to define the meiotic stage 
of nondisjunction.
The 13 single-copy sequences isolated during this 
project represent a significant contribution to the total 
number of arbitrary DNA sequences assigned to chromosome 21, 
which at present stands at 99. The recently developed 
technology of pulse-field electrophoresis will allow these 
sequences to be used in the construction of a physical map of 
chromosome 21. Those probes which detect RFLPs can also be
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incorporated into the genetic linkage map of this chromosome. 
In this way the gap between the physical map (in megabases of 
DNA ) and the genetic map (in recombination units) will be 
bridged.
Five of the single-copy sequences isolated during this 
project were also tested for expression in Northern blot 
experiments. Four were shown to be expressed - two 
(JG72/P21S92, JG108/D21S99) at a significant level only in 
Down's syndrome brain tissue; the other two (JG77/D21S93, 
JG90/D21S95) are expressed in both normal and Down's syndrome 
brain, and at a much higher level in the latter. It is 
interesting to note that JG77/P21S93 and JG90/D21S95 have 
been localised in the regions of chromosome 21 associated 
with Down's syndrome and Alzheimer's disease, respectively, 
and as such could represent genes or parts of genes involved 
in the pathogenesis of these disorders.
In the absence of an understanding of the pathogenesis 
of Down's syndrome, no rational therapy is available, and 
current emphasis must lie with prevention of the disorder. At 
the primary level, this would involve the prevention of 
nondisjunction but again this is not possible due to the lack 
of understanding of the mechanisms involved. As such, 
secondary prevention by detection and selective termination 
of pregnancy is the main focus of effort. To facilitate this 
the identification of risk factors for Down's syndrome such 
as increased maternal age and reduced levels of maternal 
serum alpha-fetoprotein is clearly important. DNA probes as
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described in this study might also be of use in the 
definition of risk factors in families showing recurrent 
trisomy 21 - by comparing pericentromeric RFLP haplotypes in 
affected family members it could be determined whether or not 
all centromeres are equally predisposed to nondisjunction. 
Furthermore, DNA probes may also be useful for diagnosis of 
Down's syndrome either by in situ hybridisation to interphase 
nuclei or by dosage studies in fetal tissues, which might be 
obtained either by conventional prenatal diagnosis techniques 
or by isolation of fetal cells from maternal blood.
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1. 1____Down's syndrome
1.1.1 Historical Aspects
In 1866 an English physician, John Langdon Down, 
published a paper entitled "Observations on an ethnic 
classification of idiots". As medical superintendant of an 
asylum for the severely mentally retarded, he found that 
approximately 10% of all the inmates resembled each other and 
could readily be distinguished from the other inmates. He 
suggested that members of this group expressed some Mongolian 
traits : "The great Mongolian family has numerous
representatives, and it is to this division I wish in this 
paper to call special attention. A very large number of 
congenital idiots are typical Mongols. So marked is this, 
that when placed side to side, it is difficult to believe 
that the specimens compared are not children of the same 
parents".
It is now clear that such terms as "Mongolian Idiot", 
"Mongol" and "Mongoloid" are not only offensive, but are also 
incorrect. Even Down's son, Reginald Langdon Down, who 
continued in his father's work with mental defectives, 
recognised this : "It would appear that the characteristics 
which at first sight strikingly suggest Mongolian features 
and build are accidental and superficial, being constantly 
associated with other features which are in no way 
characteristic of that race". Of the many substitute names 
suggested, the most commonly used is Down's syndrome.
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Long before the cause of Down's syndrome was known, 
studies of this disorder among twins suggested a genetic role 
(Halbertsma 1923; Reuben & Klein 1926). Among monozygotic 
twins (which arise from a single egg and thus have identical 
genotypes) it was found that if one member had Down's 
syndrome, almost invariably the other was similarily 
afflicted. In contrast, if one member of a pair of dizygotic 
twins (which develop from two fertilized eggs and so are 
genetically equivalent to siblings) had Down's syndrome, the 
other was, in most cases, normal.
Because the pattern of transmission did not fit the 
usual models for single gene inheritance, it was suggested 
(Waardenburg 1923) that Down's syndrome might result from a 
chromosomal abnormality. Methods then available for studying 
human chromosomes were too primitive to test this hypothesis, 
but just three years after the normal human chromosome number 
was finally established (Tjio & Levan 1956; Ford .& Hammerton 
1956), came the exciting discovery that somatic cells of 
sporadic Down's syndrome patients contain 47 chromosomes 
instead of 46 (Lejeune et al 1959a,b). The extra chromosome 
was one of the G group, at first thought to be the next to 
smallest, chromosome 21. As such, Trisomy 21 was quickly 
accepted as an alternative name for Down's syndrome. Later, 
however, improved techniques showed the extra chromosome to 
be the smallest member of the G group, which should be called 
chromosome 22, but rather than try to alter the already 
well-established name, cytogeneticists simply learned to live
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with the inconsistency. For this reason the next to smallest 
chromosome in the G group is designated 22, while the 
smallest - trisomic in Down's syndrome - is called chromosome 
21 (Ridler 1971, Baikie 1971, Hsu et al. 1971).
1.1.2 Clinical Features
Of all the disabilities in Down's syndrome, the most 
inportant, in terms of the affected individual's ability to 
cope with the environment, are those connected with mental 
development. These patients are severely mentally retarded 
and generally have an I.Q. in the range of 25-50. With a 
frequency at birth of approximately 1 in 700 (Smith & Berg 
1976), Down's syndrome thus represents the most commonly 
recognised cause of severe human mental handicap.
In addition to these obvious abnormalities of the 
central nervous system, patients are distinguished by some 
combination of the following traits : the face is broad with 
a small, flat nose, irregular teeth, and abnormally shaped 
ears. The eyes may be close set, with narrow, upslanting 
palpebral fissures; the presence of an epicanthic fold is 
common in Down's syndrome patients. The tongue is often large 
and furrowed. These dysmorphic features are very distinctive 
and allow the rapid clinical diagnosis of a high proportion 
of cases. All parts of the body are shortened, signifying 
poor skeletal development. Defects of the heart, intestines, 
kidneys, thyroid and adrenal glands are common. Males have 
poorly developed genitalia and are almost invariably sterile.
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In females, although some have reproduced, ovarian defects 
and irregular menstruation are very common.
The life expectancy of Down's syndrome patients is 
considerably reduced. Roughly half of all Down's syndrome 
patients die in the first year of life, often from congenital 
cardiac anomalies. Another major cause of death in these 
patients is respiratory infection and the mortality rate is 
approximately 120 times greater than in the general 
population. Also, for unknown reasons, there is a 20-fold 
increased risk of dying from acute leukaemia.
The application of cardiac surgery and antibiotic 
therapy has, in recent years, led to an increased survival 
rate for Down's syndrome patients. It is unlikely, however, 
that their ultimate life expectancy will be in the normal 
range, since patients who survive longer (over 35 years) 
develop neurological changes typical of Alzheimer-type
dementia (For further details and references on clinical 
features see Smith & Berg 1976 and Vogel & Motulsky 1986).
1.1.3 Cytogenetics of Down's Syndrome
The chromosome constitution most commonly associated 
with Down's syndrome is the presence of three complete copies 
of chromosome 21 in all of the cells of an individual. This 
occurs in about 95% of Down's syndrome individuals and is 
referred to as standard trisomy 21.
Another common chromosome anomaly in Down's 
syndrome is that of mosaicism, which results from mitotic
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non-disjunction in the embryo, as opposed to meiotic 
non-disjunction in the parent. The degree of abnormality in 
such patients depends upon the proportion and tissue 
distribution of trisomic cells. For example, if mitotic 
nondisjunction occurred at an early stage of differentiation, 
then a high . percentage of cells would be trisomic and the 
phenotype would show many of the characteristic Down's 
syndrome symptoms. If it took place later, such that cells of 
the nervous tissue had a normal chromosome complement, the 
individual may be of normal intelligence.
The true frequency of chromosome mosaicism is 
difficult, if not impossible, to establish, because it is 
theoretically impossible to rule out the presence of a second 
cell line in any study. In practice, however, arbitrary 
limits are usually imposed on the number of cells of 
different karyotype required for such a diagnosis. Studies of 
mosaicism in Down's syndrome individuals have shown that it 
accounts for about 1% of all cases.
In addition to standard trisomy 21 and mosaicism, two 
different classes of translocation can result in the Down's 
syndrome phenotype, and account for approximately 4 %  of 
cases. The most common is called Robertsonian translocation 
(Robertson 1916) or centric fusion (White 1954), and involves 
the translocation of the long arm of chromosome 21 to the 
long arm of either a large, or another small acrocentric 
chromosome. The complementary chromosome formed by fusion of 
the two short arms of the participating chromosomes is
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usually lost after a few cell generations. Clinically, the 
result of having an additional copy of the long arm of
chromosome 21 is the same whether or not it is attached to 
another chromosome, or isolated, as in the standard trisomic 
karyotype (Turpin & Lejeune 1961, Gustavson 1964, Gibson & 
Pozsonyi 1965, Niebuhr 1974).
Although centric fusions are the most frequent, a wide 
variety of reciprocal translocations involving chromosome 21 
have also been reported (see deGrouchy & Turleau 1977, Smith 
& Berg 1976). Some of these result in the birth of a child 
with Down's syndrome and the study of such translocations led 
to the assignment of 21q22 as the chromosomal segment 
primarily responsible for the Down's syndrome phenotype (Aula 
et al. 1973, Niebuhr 1974, Williams et al. 1975, Cervenka
et al. 1977, Summitt 1981). There is some disagreement
regarding the involvement of the specific sub-bands of 21q22 
in the determination of Down's syndrome. Some researchers 
have excluded band 21q22.3 from the critical region 
(Poissonier et al. 1976), while others have observed the 
Down's syndrome phenotype in patients that are trisomic only 
for 21q22.3 - qter (Mattei et al. 1981, Habedank & Rodewald 
1982).
1.1.4 Pathogenesis of Down's syndrome
It is generally assumed that the extra 21q22 segment 
codes for normal products and that the abnormalities observed 
in Down's syndrome are produced by the excess of some of
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those proteins. It has been estimated that the critical 
region of chromosome 21 should contain less than 100 genes 
(Smith & Warren 1985). Molecular cloning of genes from this 
area of chromosome 21 and analysis of their organisation and 
expression in normal and Down's syndrome individuals should 
lead to identification of those involved in the pathological 
manifestations of the syndrome.
At the time when the current project began, the only 
genes which had been mapped to this region of the chromosome 
were those for the cytoplasmic form of superoxide dismutase 
(SOD-1; Tan et al. 1973), phosphoribosyl glycinamide 
synthetase (PRGS; Moore et al. 1977) and the cell surface 
receptor for human interferon (IFRC; Tan et al. 1974). 
Although several hypotheses concerning the role of these 
genes have been suggested (Epstein et al. 1985), there is no 
compelling data linking altered expression of these genes to 
a specific feature of the Down's syndrome phenotype.
1.1.5 Frequency of Down's Syndrome and Parental Age Effects 
Most of the published results agree that the incidence 
of Down's syndrome at birth is of the order of 1 in 700 
(Smith & Berg 1976). The birth incidence varies greatly with 
the age of the mother. At about the maternal age of 20 years 
the incidence is 1 in 2000. This changes very little until 
age 35, when the risk is about 1 in 300. The exponential 
increase in risk continues in older mothers, such that at 45 
years and over the incidence rate is approximately 1 in 45
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(Smith & Warren 1985). The effect of maternal age in Down's 
syndrome was first described by Penrose (1933) and has 
subsequently been demonstrated in all populations studied, 
regardless of geographic location, ethnic origin or 
socio-economic status. One group of researchers have 
claimed that a proportion of Down's syndrome births are 
dependent on the age of the father and that the risk 
increases significantly after the age of 55 (Stene & Stene 
1977, Stene et al. 1977). A different method of statistical 
analysis was used by Erickson (1978), who concluded that a 
paternal age effect, independent of the age of the partner, 
was not demonstrable in his large sample. The method used by 
Erickson was criticised by Stene and Stene (1978). Subsequent 
studies have agreed with the conclusions of Erickson, 
however, and failed to demonstrate the presence of an 
independent paternal age effect (Erickson 1981, Hook et al.
1981). The situation is the source of considerable debate and 
remains unresolved.
1.1.6 Recurrence Risk of Down's syndrome
The occurrence of two or more patients with Down's 
syndrome in the same kindred has been demonstrated (Werner 
et al. 1982). Occasionally this is due to a phenotypically 
normal parent who has a low level of mosaicism but in most 
cases the parents' chromosomes are normal. The observed 
recurrence risk for young parents in this situation is 
accepted to be 1% (Daniel et al. 1982).
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1.2 Nondisjunction
1.2.1 Mechanisms producing standard trisomy
Standard trisomy 21, as opposed to translocations and 
mosaicism, is found in about 95% of Down's syndrome cases. 
Possible mechanisms resulting in the presence of three copies 
of chromosome 21 in an individual include asynapsis (failure 
of homologous chromosomes to pair), desynapsis (chromosomes 
fall apart in the absence of chiasma formation), precocious 
separation (early separation of chromosomes after chiasma 
formation has been completed) and nondisjunction (failure of 
homologous chromosomes to separate during the first meiotic 
division or failure of chromatids to separate during the 
second meiotic division). Another possible mechanism leading 
to numeric chromosome abnormalities is loss of single 
chromosomes, presumably due to "anaphase lagging" : during
anaphase movement, one chromosome may lag behind the others 
and fail to segregate properly at cell division, leading to 
aneuploidy.
All of these errors could result in the germ cell 
retaining both copies of the chromosome 21 pair, such that 
the gametic chromosome number is 24 instead of 23. Since it 
is not yet possible in man to distinguish between these 
different types of aberrant chromosomal behaviour by 
observation of the end product of meiotic division, they are 
all grouped, for convenience, under the general term 
nondisjunction.
It should be noted that desynapsis can be excluded as a 
possible mechanism in cases where recombination between 
nondisjoined chromosomes can be demonstrated.
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1.2.2 Parental Origin of Nondisjunction
Cytogenetic Studies
Following the advent of quinacrine fluorescence 
chromosome banding techniques (Caspersson et al. 1970), the 
heritable variations in staining pattern of the short arm of 
chromosome 21 have been used successfully to follow the 
inheritance of this chromosome in Down's syndrome families 
and to determine the parental origin of the extra chromosome. 
Up until 1983, a total of 369 families had been examined 
using this technique. The results of these studies are 
summarised by Juberg & Mowrey (1983), who showed that in 80% 
of cases the additional chromosome 21 was of maternal origin. 
When maternal, nondisjunction occurred at the first meiotic 
division in 77% and at second meiotic division in 23% of 
cases. Thus in approximately two-thirds of Down's syndrome 
families, nondisjunction takes place at the first maternal 
meiotic division. The fact that in 20% of cases the 
additional chromosome was derived from the father helped to 
disprove the commonly held theory at the time that Down's 
syndrome was exclusively attributable to the mother. When of 
paternal origin, nondisjunction took place at meiosis I in 
58% of cases, and at meiosis II in 42% of cases.
It should be noted, however, that determination of the 
meiotic stage of nondisjunction in Down's syndrome families 
using heteromorphisms associated with 21p is not completely 
reliable. Three main technical problems limit their overall 
usefulness. First, in the majority of cases, analysis is
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based on subjective evaluation of the size and staining 
intensity of the chromosomal heteromorphisms. Even when the 
scoring of different variants is done blindly, and by 
independant observers, it is possible that a small proportion 
of parental origin assignments will be wrong. Secondly, 
cytogenetic analyses of Q-banding heteromorphisms are 
informative in only 50% of cases. When combined with the 
NOR-silver staining technique, this figure rises to 80% 
(Mikkelsen et al. 1980), but this still leaves one fifth of 
cases in which the origin of nondisjunction cannot be 
determined. Thirdly, recombination between the centromere 
and the short arm markers could lead to errors in the 
localisation of nondisjunction to a specific meiotic 
division.
1.2.3 Parental Origin of Nondisjunction
Use of Polymorphic DNA Markers
Polymorphic DNA markers are those which allow the 
detection of restriction fragment length polymorphisms 
(RFLPs). These are heritable variations in DNA sequence 
detected by differences in the band pattern shown by a 
particular cloned DNA probe in Southern blot experiments 
(Botstein et al. 1980). They represent codominant heritable 
markers and can be used to follow the inheritance of a 
particular chromosome or chromosomal region. Consequently, 
any polymorphic DNA probes isolated from chromosome 21 can be 
used to follow the inheritance of that part of the chromosome
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within Down's syndrome families, thereby allowing the 
determination of the parental origin and in some cases the 
meiotic stage of nondisjunction.
The use of RFLP markers overcomes two of the problems 
inherent in the cytogenetic analysis of chromosome 
heteromorphisms mentioned previously. Firstly, the detection 
of allelic variation using RFLPs is objective and it is clear 
from the relative dosage of the bands which chromosome is 
present in more than one copy in the DNA of the child. 
Secondly, the potential availability of a large number of 
polymorphic DNA markers from chromosome 21 should allow the 
origin of the additional chromosome to be determined in most, 
if not all, cases.
One problem common to both cytogenetic and RFLP 
studies of the origin of nondis junction is that of 
recombination. Crossing-over can occur between the centromere 
and the polymorphic DNA markers on the long arm of the 
chromosome, and although this would not affect determination 
of parental origin of nondisjunction, it may lead to errors 
in the localisation of nondisjunction to specific meiotic 
division. The use of RFLP markers close to the centromere 
would obviously reduce the risk of this. It should also be 
possible, using a sufficient number of polymorphic DNA 
markers dispersed along the long arm of chromosome 21, to 
detect the frequency and position of recombination events at 
any given meiosis.
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1.2.4 Parental Origin of Nondisjunction
Combined Use of RFLP and Cytogenetic Methods
It seems obvious from the foregoing discussion that 
the origin of nondisjunction in Down's syndrome families 
could be analysed by a combined study of both cytogenetic 
heteromorphisms and polymorphic DNA markers (including at 
least one from the pericentromeric region). In this way the 
centromere could be "sandwiched" between polymorphic markers 
on the short and long arms. If these were concordant, then 
the parental origin and meiotic stage of nondisjunction could 
be stated with a high degree of confidence.
1.2.5 Possible Effects of Aberrant Levels of
Recombination on Nondisjunction
In species with chiasmate meioses, maintenance of
pairing at meiosis I is presumably dependant on the formation
of at least one chiasma per bivalent (White 1973). Thus, 
reduction or elimination of crossing-over may lead to 
univalent formation, and ultimately to nondisjunction. There 
is some evidence from experimental animals (Henderson & 
Edwards 1968, Sandler 1981) to suggest that this might be an 
important source of trisomy. Furthermore, if multiple
exchanges impede the normal separation of bivalents at
anaphase I, abnormally high levels of recombination might 
also be associated with nondisjunction.
It is now possible to test these suggestions directly 
in humans using the technique of centromere mapping
({Ottt et al. 197€>)) to compare the frequency of crossing-over 
in normal ineioses and iteioses reselling in trisomy. 
Chromosome heteranoiphisns anc|/or periceotroierlc KELPS are 
used to determine the meiotic stage of origin of the 
additional chrcmiiosoiiie. Distances from the centromere to the 
KELP markers are them estimated by evaluating the level of 
heterozygosity among trisomic KEIPS for which the parent of 
origin is known to be heterozygous. m  trisomy of meiosis I 
origin, increasing homozygosity is directly proportional to 
increasing centroneric distance- in trisomy of meiosis II 
origin the converse is tree.
the combined use of pericentrcmeric KELP and 
cytogenetic markers with more distal KELP markers on 21q In 
this; way should allow levels of recombination on nondisjoined 
chromosomes 21 to be estimated. Comparison with chromosomes 
involved In normal meioses should allow the possible effects 
of aberrant recombination on nondis junction to be evaluated.
Page 26
1.3 Aetiological Factors
Despite years of intensive study, advanced maternal 
age remains the only risk factor conclusively associated with 
nondisjunction in Down's syndrome. The failure to identify 
important risk factors may be due to the fact that 
researchers have failed to study the appropriate aetiological 
agents or populations at risk. Another possibility is that 
studies to date have been badly designed. One of the major 
problems associated with studies of nondisjunction is that 
the populations studied are intrinsically heterogeneous, and 
each of the four types of meiotic error (maternal/paternal, 
first/second division) may be caused by different 
environmental and stochastic factors. This situation should 
be resolved by the objective determination of parental origin 
and meiotic stage of nondisjunction in a large, coordinated 
study of Down's syndrome families. The risk factors for each 
type of meiotic error could then be analysed independantly. 
A discussion of the maternal age effect is presented below, 
and is followed by a brief summary of other proposed risk 
factors.
1.3.1 Maternal Age
The frequency of Down's syndrome births increases 
with maternal age, and as the risk shows an exponential 
increase in the mid 30's, prenatal diagnosis is usually 
recommended to all pregnant women over the age of 35. The 
most popular theory put forward to explain the higher
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incidence of nondisjunction in older mothers is the "older 
egg" model. This refers to the cycle of meiosis in female 
mammals, which begins shortly before birth or in early 
postnatal life (Franchi et al.1962). Following the leptotene, 
zygotene, pachytene and diplotene phases, the resting stage 
of dictyotene is reached. The oocyte remains in this 
condition until its final maturation at the time of formation 
of the Graafian follicle. The first meiotic division is then 
completed with the extrusion of the first polar body. The 
human female reproductive capacity lasts from about the ages 
of 15 to 50 years and the oocytes remain in the dictyotene 
stage during this period. It is thought likely that harmful 
effects of the environment or deterioration of the nucleus 
may occur during this period, leading to aberrant segregation 
of the chromosome 21 pair and subsequent aneuploidy.
Given that the majority of nondisjunction errors occur 
during maternal meiosis I (see section 1.2.2), it is expected 
from this model that the the ratio of maternally to 
paternally derived cases (the M/P ratio) should increase very 
sharply with advancing maternal age. This is apparently not 
the case, however, as approximately 80% of nondisjunction 
errors involving chromosome 21 occur in maternal meiosis I, 
regardless of maternal age, and the M/P ratio changes very 
little with maternal age (Stein et al. 1986). These 
observations suggested that a mechanism other than 
age-related deterioration of the nucleus might be involved, 
and led to the proposal of the "relaxed selection" hypothesis
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(Erickson 1978, Sved & Sandler 1981, Ayme & Lippman-Hand
1982). This theory states that older mothers lose the ability 
to reject trisomy 21 conceptuses, resulting in a higher 
incidence of liveborn infants with Down's syndrome.
All of the experimental evidence for an association 
between advanced maternal age and "relaxed selection" against 
trisomy 21 embryos is derived from the use of cytogenetic 
heteromorphisms on 21p to determine the parental origin of 
the additional chromosome 21. The possible errors inherent in 
this method (see section 1.2.2) may affect the results 
obtained in such studies. Indeed, other workers have 
expressed reservations about certain aspects of the data and 
methods quoted in support of the "relaxed selection" theory 
(Carothers 1983, Warburton 1983).
The available data do not allow a clear distinction 
between the "older egg" and "relaxed selection" models. It is 
possible that both mechanisms are involved. The resolution of 
this situation will involve a large, coordinated study, using 
both cytogenetic and polymorphic DNA markers to determine 
with confidence the origin of nondisjunction in Down's 
syndrome families (see section 1.2.4).
1.3.2 Other Candidate Risk Factors
Cytogenetic and epidemiological studies have 
identified many candidate risk factors including extraneous 
ones such as oral contraceptives (Harlap 1979), fertility 
drugs (Boue & Boue 1973) maternal irradiation (Uchida 1979),
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cigarette smoking (Kline et al. 1983) and alcohol (Kaufman
1983). Some intrinsic risk factors have also been proposed, 
such as the presence of anti-thyroid autoantibodies (Fialkow 
et al. 1971), sharing of HLA antigens among parents 
(Mottironi 1983), and increased frequency of satellite 
associations between acrocentrics (Jacobs & Mayer 1981). 
Clear evidence of an association with these factors and the 
occurrence of Down's syndrome is still lacking in each case.
Some models have also been proposed involving specific 
genes which promote nondisjunction. One such theory suggests 
that an autosomal recessive gene which causes meiotic 
nondisjunction in a homozygous parent may be responsible 
(Holmes 1978). Another postulates the existance of a gene 
which induces mitotic nondisjunction in the homozygous 
fertilised ovum (Alfi et al. 1980). Direct evidence for both 
theories is currently lacking, however.
1.3.3 Recurrence Risk of Down's syndrome
Another possible factor involved in the aetiology of 
Down's syndrome is that there appears to be a tendency for 
more than one case of Down's syndrome to occur in certain 
families. As mentioned previously (section 1.1.5) the 
recurrence risk for this condition in non-mosaic couples with 
one affected child is approximately 1% (Daniel et al. 1982). 
The birth of a child with Down's syndrome raises the risk of 
having another trisomic child, whether or not chromosome 21 
is involved.
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It is also interesting that the risk to second degree 
relatives also seemed to be increased beyond that of the 
general population. A study of such individuals (Tamaren 
et al. 1983) suggested a risk of 0.67% of having a Down's 
syndrome child in the second degree relatives of such 
patients. Two more recent studies (Eunpu et al. 1986, Abuelo 
et al. 1986) dispute this finding, however, and state that 
the risk factor for second-degree relatives is not greater 
than in the general population.
These results suggest that some inherited factor may be 
involved in the aetiology of Down's syndrome. It may be the 
case that all chromosome 21 centromeres are not equal, and a 
predisposition to nondisjunction might then exist in certain 
individuals. This theory could be tested using polymorphic 
chromosome 21-specific DNA markers (see section 1.2.3) to 
determine whether a particular pericentromeric haplotype of 
RFLP markers might be associated more often than expected 
with nondisjoined chromosomes 21.
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1.4 Molecular Analysis of Chromosome 21
Chromosome 21 is the smallest autosome, comprising only 
1.7% of human DNA* (HGM 9, 1988). At the outset of this
project, only 12 cloned genes and 9 anonymous DNA sequences 
had been mapped to this chromosome (HGM 7, 1984). The
availability of chromosome specific recombinant DNA libraries' 
and advances in the field of somatic cell genetics, however, 
would allow the rapid isolation and regional localisation of 
numerous cloned DNA segments for this chromosome.
Much of the interest in chromosome 21 can be attributed 
to its association with Down's syndrome and the fact that 
isolation of cloned DNA segments from the critical region of 
this chromosome allows the pathogenesis of the disease to be 
analysed at the molecular level. One of the ultimate aims of 
molecular genetic investigation of chromosome 21 is that it 
may eventually lead to the elucidation of molecular events 
leading to meiotic nondisjunction and consequent trisomy.
Many DNA sequences isolated from chromosome 21 detect 
RFLPs (almost 35% - see HGM 9, 1988) and therefore represent 
useful genetic markers. In addition to the analysis of 
nondisjunction in Down's syndrome families, these probes 
could be used to construct a genetic linkage map of 
chromosome 21, and to demonstrate linkage or non-linkage with 
genetic disease loci of unknown chromosomal origin.
Other possible uses for chromosome 21-specific DNA 
sequences, whether or not they detect RFLPs, are in (i) the 
isolation of genes from chromosome 21 by screening cDNA
(* - this corresponds to approximately 51 rnegabases of DNA)
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libraries with cloned chromosome 21-specific DNA sequences 
(e.g Neve et al. 1986); and (ii) in chromosome "walking" and 
"jumping" experiments. Starting from an original cloned DNA 
sequence, these techniques essentially involve the isolation 
of either overlapping/flanking clones ("walking" - Steinmetz 
et al. 1984) or clones at some distance from the original one 
("jumping" - Collins & Weissman 1984, Poustka et al. 1987). 
This means that DNA sequences not closely linked to an 
original clone can lead to the isolation of genes and/or 
sequences important in the pathogenesis of inherited 
disorders.
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1.4 Aims of the Current Project
The general aim of this research project was the 
isolation of polymorphic DNA sequences from chromosome 21 
which could be used to study the parental origin of 
nondisjunction in Down's syndrome families and in molecular 
genetic analysis of this chromosome. Specifically, the aims 
were as follows.
1. Screening of Chromosome 21-Specific Recombinant 
DNA Libraries
Clones containing single- or low-copy number human DNA 
sequences would be isolated from flow sorted chromosome 
21-specific libraries.
2. Mapping of Sequences to Chromosome 21
Human DNA sequences would be mapped to chromosome 21 
and regionally localised using a panel of somatic cell 
hybrids containing different translocation derivatives of the 
chromosome.
3. Testing of Cloned Probes for the Detection of 
Restriction Fragment Length Polymorphisms (RFLPs) 
Chromosome 21-specific DNA probes would be tested for
the ability to detect frequent RFLPs by hybridisation to DNA 
samples from different individuals digested with a range of 
restriction enzymes.
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4. Analysis of Nondisjunction in Down's Syndrome Families 
Polymorphic chromosome 21-specific DNA probes would be
used in conjunction with similar probes provided by other 
groups and with the analysis of Q-banding heteromorphisms to 
determine the parental origin ana, where possible, the 
meiotic stage of nondisjunction in Down's syndrome families. 
The use of RFLP markers overcomes some of the problems 
inherent in previous, cytogenetic studies of nondisjunction 
and the effectiveness of the two methods could be compared.
5. Analysis of Recombination Levels in Chromosomes 21 
Undergoing Nondisjunction
Studies on animal models have indicated that aberrant 
levels of recombination between homologous chromosomes may be 
important in nondisjunction. As part of the study of Down's 
syndrome families, the inheritance patterns of different RFLP 
markers would be studied to determine whether recombination 
on nondisjoined chromosomes 21 could be detected.
6. Molecular Genetic Map of Chromosome 21
It was also hoped that the isolation and regional 
localisation of chromosome 21-specific DNA sequences during 
the current project would significantly augment the molecular 
map of chromosome 21 , which contained only 9 anonymous DNA 
sequences when this project began. Any probes detecting RFLPs 
could potentially be incorporated into a genetic linkage map 
of the chromosome.
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7. Testing of DNA Sequences for Expression using
the Northern Blot Technique
Chromosome 21-specific DNA sequences isolated during 
the current project would be tested in Northern blot 
experiments to determine whether or not they were expressed 
sequences. If any of the sequences localised to the Down's 
syndrome critical region were expressed, it is possible that 
they may represent genes directly involved in the 
pathogenesis of the disorder.
CHAPTER TWO
MATERIALS & METHODS
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2.0 General
All aqueous solutions were prepared in water deionised 
by a Millipore "Milli-RO 15” water purification system. If 
required, solutions were sterilised in a pressure cooker at 
151bs/ina for 15-20 minutes.
Glassware, plastics and tips for micropipet ting were 
sterilised in a Sybron/Drayton Castle industrial autoclave 
for 20 minutes and dried in an 80|C oven for 1-2 hours prior 
to use.
Plastic tubes (13ml, 30ml, 1.5ml and 0.5ml) were
supplied by Sarstedt, as were all tips for micropipetting. 
Plastic universal (30ml) and Bijoux (7ml) bottles were 
Sterilin types 128B and 129C, respectively. Micropipettes 
were Gilson "Pipetman" type. Petri dishes were Nunc (220cm 
square plates, 13cm and 9cm) or Sterilin (9cm).
Centrifugation was carried out in a Sorval RC-5B 
refrigerated centrifuge or OTD-65 ultracentrifuge, an 
Eppendorf or Damon micro-centrifuge. Rotors are specified in 
the text.
Practical details and applications of many recombinant 
DNA techniques can be found in Maniatis et al. (1982).
2.1 Reagents
10Ox Denhardts Solution 
2% Ficoll
2% Bovine serum albumin 
2% Polyvinylpyrrolidone
20xSSC (Standard Saline Citrate) 
for 5 litres:
441g Tris.HCl (pH7.2)
877.5 ml Nad
TE
10mM Tris.HCl pH8.0 
ImM Na EDTA pH8.0
Bacteriophage dilution buffer 
0.1M Tris.HCl pH8.0 
0.1M MgS04 
0.1% Gelatine (w/v)
,fEfl buffer (Electrophoresis buffer) 
40mM Tris-acetate pH8.0 
20mM Sodium or potassium acetate 
ImM Na EDTA
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L-broth (per litre) 
lOg Bacto-tryptone 
5g Bacto-yeast extract 
lOg NaCl 
0.1% Maltose 
lOmM MgS04
Maltose : 20% stock solution, filter sterilized 
Bottom agar : 15g of agar was added per litre of L-broth 
Top agar : 7g of agar was added per litre of L-broth
Agar was melted by autoclaving in a pressure cooker, and 
cooled to approximately 45°C before use.
Ampicillin
Stock solution of 25mg/ml was prepared by dissolving the 
appropriate amount of powdered ampicillin in distilled water. 
This solution was stored at -20°C.
X-Gal (5-Bromo-4-Chloro-3-Indoyl-beta-D-Galactopyranoside) 
Stock solution was prepared by dissolving lOOmg X-Gal in 5ml 
dimethylformamide. This solution was stored at -20°C in a 
light-tight container.
Formamide
Formamide was deionised by stirring at 4°C for 4-5 hours with 
approximately 5g of Bio-Rad mixed bed resin (20-50 mesh). It 
was subsequently stored at -20°C.
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Phenol
Phenol was distilled in this department using Quickfit 
distillation apparatus. It was stored at 4°C until required. 
8-hydroxyquinoline was added to give a yellow colour, which, 
if lost, would indicate oxidisation of the phenol.
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2.2 Hybrid Cell Lines used in the Regional Localisation
of DNA Sequences to Chromosome 21
A brief description of each cell line is given below, 
together with an explanation of how they can be used to map 
DNA sequences on the chromosome. Schematic representations of 
the parts of chromosome 21 found in the various hybrids are 
shown in the Results section, Figures 2, 6, 8 and 11.
(Note - to facilitate interpretation of results obtained 
using DNA samples from the panels in Figures 6 and 8, 
additional, unbound copies of these Figures can be found 
inside the back cover of this thesis)
THYB133R is a derivative of THYB133 (Goodfellow et al. 
1980) obtained from Dr.C.Bostock and contains chromosome 21 
as its only detectable human chromosome against a mouse 
background. Any human sequences which hybridise to DNA from 
this cell line can therefore be assigned to chromosome 21.
AlWBf2 was constructed from fusion of human lymphocytes 
from a female carrying a 12;21 transloaction with Chinese 
Hamster A3 cells. Although a few other human chromosomes are 
found in this hybrid, the only chromosome 21 material present 
is the 21q21-qter region. Sequences from chromosome 21 which 
hybridise to the DNA of this cell line must therefore be 
derived from this part of the chromosome.
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A1WC6 contains the reciprocal product of the 12; 21 
translocation present in AlWBf2, that is, the region 
21pter-21q21. DNA clones can thus be mapped to this part of 
the chromosome using DNA from this hybrid cell line. Cell 
lines AlWBf 2 and A1WC6 were obtained from Prof .P. Pearson.
AHVI-17 was constructed by fusion of mouse A9 cells 
with a human fibroblast line (GM1881; Camden Human Genetic 
Mutant Cell Repository) which carries a reciprocal balanced 
1; 21 translocation. This hybrid cell line contains the 
21pter-21q22.1 region of chromosome 21 as part of the 1;21 
translocation chromosome. Although neither the reciprocal 
part of the translocation nor the normal chromosome 21 are 
found in this hybrid, it does contain a number of additional 
human chromosomes. Chromosome 21 sequences hybridising to 
the DNA of this cell line can be assigned to the region 
21pter-21q22.1; lack of hybridisation would consequently 
assign the sequence to the region 21q22.1-21qter. This cell 
line was obtained from Prof.D.Cox.
BW5147 (Hyman and Stallings 1974) is a mouse cell line, 
obtained from Dr .P.Goodfellow. It was included in the panel 
to ensure that hybridisation of probes to the hybrid cell 
line DNA samples was due to hybridisation to sequences on 
chromosome 21 and not a consequence of homology with murine 
DNA. Given the similarities between human trisomy 21 and 
mouse trisomy 16 (Epstein et al. 1985), it would also be
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interesting to determine whether any of the probes isolated 
here did share any homology with murine DNA sequences.
Further details on the five cell lines mentioned above, 
including photographs showing the derivative chromosomes 
where appropriate, are given in Stewart (1984).
TTD2
This is a human fibroblast cell line with the 
chromosome constitution 45XX,-21,+t(4;21)(pl6.3,q21). One 
part of the reciprocal translocation is not present, and so 
this individual is essentially monosomic for the region 
21pter-q21. This cell line was included to map probes by 
virtue of the relative signal dosage in Southern blot 
experiments between this hybrid and normal genomic DNA. This 
cell line was obtained from Dr.N.Carpenter.
72532X-6 is the result of a fusion involving Chinese 
Hamster ovary (CHO) and human cell lines. It contains 
chromosome 21 as its sole human chromosome. This hybrid and 
all hybrids mentioned subsequently were kindly supplied by 
Dr.D.Vannais/Prof.D.Patterson; further details on the 
construction and characterisation of these hybrids can be 
found in Patterson et al. (1985) and Van Keuren et al. 
(1986a,b).
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153E7BX and 2Furl contain part of the long arm of 
chromosome 21 translocated to a Chinese Hamster chromosome. 
The former contains the region 21pll. l-21qter; it may also 
contain sequences above the pll.l breakpoint, but analysis 
has so far failed to clarify this situation. The latter 
contains the 21qll.2-qter region. Neither hybrid contains any 
other human chromosomal material. DNA probes can be mapped to 
or excluded from these areas of the chromosome based on 
hybridisation or lack of hybridisation to the DNA of these 
cell lines.
R2-10 contains a ring 21 as its only human chromosome. 
It was constructed by fusion of a CHO mutant cell line 
deficient in GARS activity with a human cell line mosaic for 
a ting chromosome 21 with a breakpoint in q22.3. This hybrid 
contains the region 21pll.2-q22.3, and human DNA probes 
hybridising to the DNA of this line can be localised to this 
chromosomal region.
8q- contains the 8; 21 translocation chromosome 
8pter-q22.1::21q22.3-qter. The only part of chromosome 21 
present, therefore, is the terminal part of band q22.3. Any 
DNA probes which hybridise to the DNA of this cell line must 
be derived from the terminal part of the q22.3 band.
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ACEM2-90 was derived from fusion of Chinese Hamster 
cells with those of a Down's syndrome patient carrying a 
21;21 translocation (Bradley et al. Trisomy 21, in press). 
This translocation chromosome is thought to have arisen from 
a series of complex rearrangements and contains the regions 
21cen-21pll.2 and 21q22.1-qter.
Normal human and trisomy 21 DNA samples were included 
in the mapping panels. It was hoped that increased dosage of 
hybridisation signals would be evident between normal and 
trisomy 21 samples. As the same amount of DNA from each was 
added to the gel, this effect would be due to the extra copy 
of chromosome 21 in Down's syndrome individuals, and would 
support the localisation of DNA probes to chromosome 21.
HD4 contains the reciprocal product of the 8; 21 
translocation present in the 8q- cell line, and therefore 
contains all of chromosome 21 except the terminal sub-band 
21q22.3. Any DNA probes failing to show hybridisation to DNA 
from this cell line can be mapped to the 21q22.3 region.
It should be noted that "8q-" and "HD4" are convenient 
abbreviations for these cell lines, their correct names being 
13blS816-10-3 and 21-8-Ab5-23a, respectively, as described by 
Van Keuren et al. (1986b).
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2.3 Methods used in the Plating Out and Screening 
of the Recombinant Bacteriophage Libraries
2.3.1 Preparation of plating bacteria
The bacterial strain used was E.coli LE392. A single 
colony picked from an L-agar plate or 10pl taken from a 
glycerol stock was innoculated into a 50ml L-broth (see 
general section) in a 250ml conical flask. This culture was 
incubated with shaking overnight at 37°C in an orbital shaker 
(New Brunswick Scientific). To aid the absorption of 
bacteriophage lambda to the host bacteria, 0.2% maltose was 
added to the culture medium.
The cells were spun down in plastic universal 
containers at 2,500rpm for 15 minutes at room temperature. 
The supernatant was discarded and the cell pellet resuspended 
in sterile lOmM MgSO^ to give an 0*D*goo
g
represents approximately 1.5 x 10 cells per ml. The 
bacterial suspension was stored at 4°C and could be used for 
up to two weeks. The highest plating efficiency was obtained 
with fresh cells, however. Glycerol stocks were made 
following the simple procedure described in section 2.4.9.
2.3.2 Plating and titration of the libraries
In order to determine the titre of the library, 
ten-fold serial dilutions were prepared in phage dilution 
buffer in a final volume of 1ml in 1.5ml Eppendorf tubes. The 
suspension was thoroughly mixed before 0.1ml of each dilution
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to be assayed was dispensed into sterile bijoux containing 
lOOpl of plating bacteria. The mixture was vortexed and 
incubated for 20 minutes at 37°C to allow the bacteriophage 
particles to adsorb. Molten top agar (about 5mls) was added 
to each of the bijoux bottles, and immediately poured onto 
labelled plates containing 25-30ml of solid bottom agar. The 
plates were left standing half covered to allow the top agar 
to dry without producing condensation on the lids of the 
petri dishes. When the top agar had set, the plates were 
inverted and incubated o/n at 37°C. The number of plaques on 
each dilution plate was counted, and the titre of the 
original suspension was calculated. The libraries used in 
this study were found to be in the range 2 - 6 x 10"^ pfu/ml.
2.3.3 Screening of the Recombinant Libraries
Two different recombinant libraries were used in the 
present study. These were screened using different 
strategies, as outlined below. Methods common to the 
screening procedures used with both libraries will be 
discussed first, followed by a description of the differences 
between the two methods.
2.3.4 Plating of the Libraries for Screening
For initial screening, the libraries were plated out 
at a sufficiently high density to cover chromosome 21 at 
least three times. Given the insert sizes of the libraries 
used here, this was found to correspond to approximately
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10,000-20,000 plaques. These were plated out on large (220cm 
square) plastic culture plates. The procedure used for 
plating of the libraries was the same as that described 
previously for titration of the library, except that the 
number of phage used initially was calculated to give the 
desired number of plaques on the plates.
After o/n incubation the plates were placed at 4°c for 
10-15 minutes to harden the top agar. This prevents the top 
agar peeling off when it comes in contact with the nylon 
membrane (Hybond-N, Amersham). The filter was placed 
carefully on the surface of the plate so that it came into 
direct contact with the plaques, which quickly transferred 
onto the filter. Both filter and plate were marked at the 
same locations using an ink marker (Pentel marker, black ink, 
types N50 or MS50 - this is the only ink not removed during 
the hybridisation procedure). After 30-60 seconds the filter 
was peeled off using blunt-end forceps and immersed, DNA side 
up, in a shallow tray of denaturing solution (1.5M NaCl, 0.5M 
NaOH) for 30-60 seconds. The filter was then transferred to 
neutralising solution (1.5M NaCl, 0.5M Tris.HCl pH8.0) for 5 
minutes. The filter was finally rinsed twice in 2xSSC and 
placed on Whatman 3MM paper to dry. Subsequent impressions of 
the same plate were left on the plate about 30 seconds 
longer, or until the filter was completely wet. When dry, the 
filters were wrapped between sheets of Whatman 3MM paper and 
baked for five hours at 80°C in a vacuum oven to fix the DNA 
to the filter.
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2.3.5 Prewashing and washing conditions
After baking, the filters were placed in heat-sealed 
plastic bags containing approximatley 100ml of prewashing 
solution (50mM Tris.HCl pH 8.0, 1M NaCl, ImM EDTA, 0.1% SDS). 
The filters were incubated with gentle shaking, for 2 hours 
at 42°C. The prewashing solution removes from the filters any 
fragments of agarose or bacterial debris. The pre­
hybridisation, hybridsation and posthybridisation conditions 
were as described below for gel filters.
2.3.6 Picking Plaques
Following the initial selection of plaques according 
to the screening method used, they were subjected to several 
purification steps. These differed for the two libraries, but 
the main practical points of the technique are the same, and 
will now be described.
Bacteriophage can diffuse condiserable distances 
across the layer of top agar, and so to avoid cross­
contamination between neighbouring plaques, a low density of 
bacteriophage was plated out for such purification steps, for 
the same reason, this procedure was carried out as quickly as 
possible after plating. An effort was made to choose plaques 
that were well separated from each other. After the films had 
been exposed and developed, they were aligned with the 
plates, and individual plaques were picked. The plaques were 
picked using a glass Pasteur pipette (Bibate) with a rubber 
bulb. The fragments of agar were washed into 400pl of
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bacteriophage dilution buffer. This was put into a 500pl 
Eppendorf tube and a drop or two of chloroform was added. The 
tubes were shaken for 30 minutes at 37°C in an orbital shaker 
to allow the phage particles to diffuse from the agar. These 
tubes were then stored at 4°C indefinitely.
2.3.7 Making High Titre Stocks
High titre stocks from those phage to be studied 
further were made as follows. They were plated out at a 
sufficiently high density to give confluent lysis, and 
therefore maximum yield of phage. After o/n incubation, 5ml 
of SM (per litre: 5.8g NaCl, 2.0g MgS04, 50ml 1M Tris.HCl pH 
7.5, 5.0ml 2% gelatin) was added to each plate. The plates 
were then shaken gently at 4°C for several hours. As much as 
possible of the SM was recovered with a plastic pipette and 
put into a 13ml tube. A further 1ml of SM was added to the 
plate to rinse the surface, and the plate was stored for 15 
minutes in a tilted position to allow all the fluid to drain 
into one area. The SM was again collected and added to the 
first harvest. The plates were discarded and 0.1ml of 
chloroform was added to each tube. These were then vortexed 
briefly and centrifuged for 10 minutes at 4,000rpm at 4°C. 
The supernatant was transferred to a fresh tube, chloroform 
was added to 0.3% and, after mixing the suspension very well, 
the stocks were stored at 4°C.
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2.3.8 Selection Strategies : (i) Flow Sorted Chromosome 21
Library of Young et al. (1983)
The flow sorted chromosome 21-specific library 
obtained from Dr.B.D.Young was cloned into the Eco Ri site of 
the bacteriophage vector lambda gt.WES/lambda B. The library 
was estimated to contain 60% chromosome 21 and 40% 
chromosome 22 sequences (B.D.Young, personal communication). 
This library was screened using the following method, which 
was intended to select for recombinants containing 
single-copy, expressed sequences.
Duplicate filter impressions from the initial, high 
density library plates were taken. One of these was 
prehybridised as normal, while the other was prehybridised in 
the presence of a large amount of unlabelled, sonicated human 
genomic DNA (final concentration lmg/ml of prehybridisation 
solution). Both filters were then hybridised with a 
radiolabelled cDNA probe, prepared by reverse transcription 
(See section 2.6.4). The theory behind this was that the 
prehybridisation of filters with cold genomic DNA would 
"saturate" them, such that any clones containing repetitive 
DNA sequences would hybridise to this non-labelled DNA, and 
would therefore be unavailable for hybridisation to the 
labelled cDNA probe.
The mRNA from which the cDNA was prepared came from 
the liver of a Down's syndrome foetus. The reasons for using 
this were as follows: (i) any genes important in Down s
syndrome would be present in more copies, due to the presence
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of the additional chromosome 21, (ii) fetal tissue was used 
because genes important in the development of Down's syndrome 
may be expressed in the early stages of fetal life and 
"switched off" thereafter, (iii) use of liver tissue would 
increase the probability of isolating genes important in many 
biochemical pathways, since a great number of enzymes are 
expressed in these tissues, and (iv) cDNA was used to allow 
protein-coding genes to be isolated, since these are more 
likely to be directly involved in the pathogenesis of this 
disorder.
Plaques which hybridised to cDNA and which showed
similar signal intensity in the autoradiographs from both 
filters, despite the competition with cold human DNA, were 
selected for further study. These were then picked as
described in section 2.3.5 and then subjected to a
purification procedure which involved repeating the steps of 
plating out, preassociation with cold genomic DNA and
hybridisation with labelled cDNA. This was done four times to 
ensure that the plaques were pure and contained DNA from only 
one recombinant bacteriophage. Bacteriophage DNA was then 
prepared as described in Section 2.3.9.
2.3.9 Selection Strategies : (ii) Flow Sorted Chromosome 21
Library from the Lawrence Livermore Laboratory
A much simpler selection system was used with this 
library. Basically, impressions were taken from the initial 
plating out of the library. These were prehybridised as
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normal (i.e. without cold human DNA) and then hybridised with 
labelled total genomic DNA. It was hoped that any plaques 
containing repetitive human DNA inserts would hybridise with 
the genomic DNA. Plaques which did not hybridise with genomic 
DNA were picked, in the hope that they would contain low- or 
single-copy DNA inserts. They were then purified by two 
rounds of plating out and picking a single plaque at random, 
without further hybridisation/ autoradiography. A high titre 
stock was then made from each candidate single-copy plaque. 
Bacteriophage DNA was prepared from each of these as 
described in the following section.
2.3.10 Preparation of Bacteriophage DNA
A liquid lysate method was used for the preparation 
of bacteriophage DNA. This was adapted from the method of 
Cameron et al. (1977). Two different versions of the same 
method were used, a large (500ml) and a small (5ml) scale. 
For the initial preparation of DNA from plaques of unknown 
content, the small scale method was used. The larger prep, 
was used for making bulk stocks of DNA for clones of known 
value. For convenience, only the former is described here. 
The protocol can be altered for larger or smaller scale DNA 
preparation by altering the amounts pro rata.
Large Scale Bacteriophage DNA Preparation
An aliquot of plating cells (Section 2.3.1) was 
incubated with the appropriate volume of bacteriophage. For a
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500ml culture, lOmls of plating bacteria were used (an
overnight bacterial culture typically contains 2.0 x 109
cells/ml, this volume thus represents 2.0 x 1010 cells).
A ratio of 1:200 (bacteriophage : bacterial cells) was found
o
to be optimum for this preparation, and so 10 bacteriophage 
were added to the bacterial cells in a universal. The mixture 
was incubated at 37°C for 15-20 minutes to allow the 
bacteriophage to adsorb, added to 500mls of prewarmed
L-broth, and incubated at 37°C with shaking overnight.
Lysis was evident by the presence in the culture of 
"stringy" pieces of bacterial debris. The culture was split 
between two 250ml plastic tubs. (Further steps in the 
protocol refer to individual tubs, until the samples are 
pooled). DNase was added to a final concentration of 5|ig/ml 
and the mixture incubated at 37°C for 1-2 hours. Addition of 
40mls of TES (0.3M Tris.HCl pH9.0, 0.15M EDTA, 1.5% SDS) was 
followed by incubation at 70°C for 30 minutes. The mixture
was cooled to room temperature and 50mls of 5M Potassium
Acetate was added. The tubs were incubated on ice for 30 
minutes and spun at 7k ,4°C,20 minutes in an HS-4 rotor. The 
pellet was discarded and 80ml propanol added to the 
supernatant in a fresh tub. The mixture was spun at 7K,4°C 
for 30 minutes as above. The pellet was drained thoroughly 
and resuspended in TE buffer. At this point the pellets were
pooled and transferred to 13ml plastic tubes.
Two volumes of cold (-20°C) ethanol were added and the 
tubes were placed at -20°C for 15-20 minutes. They were then
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spun at 9K for 10 minutes in an SM24 rotor. The pellet was 
washed in 70% ethanol before repeating the last 
centrifugation step. The pellet was dried thoroughly and 
resuspended in 1ml of TE buffer. RNase was added to a final 
concentration of lOOpg/pl and the mixture was incubated at 
37°C for 1 hour. Proteinase K (50pl) and 10% SDS (50pl) were 
added, followed by incubation at 55°C for l-2hours. The 
addition of 3mls of 1M Tris.HCl pH7.5 was followed by phenol 
extraction and ethanol precipitation. The final pellet was 
resuspended in approximately 1ml of TE buffer. The 
concentration of the DNA was measured by determining the
0Do^n, as described in section 2.5.5.260
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2.4 Subcloning of Recombinants into a Plasmid Vector
Once it had been established that the bacteriophage 
clones contained single- or low-copy number chromosome 
21-specific sequences, it was decided that it would be more 
convenient to have them subcloned into a plasmid vector. The 
main reasons for this were - (i) it is easier to culture and 
prepare DNA from plasmid clones, and (ii) the maintenance of 
fresh stocks of plasmid clones is also relatively simple.
The chosen plasmid vector was pUCl9, a derivative of 
pBR322 developed by Dr.J.Messing and co-workers (see Viera & 
Messing 1982). This plasmid has a useful multi-cloning site, 
and has ampicillin and tetracycline resistance genes. 
Recombinant clones can also be identified using a blue/white 
screening system, as outlined in section 2.4.5. Methods 
involved in the subcloning of human DNA inserts into the 
plasmid vector were as follows.
2.4.1 Production of Competent Cells
The strain of bacteria used for transformation was
E.coli JM83. An aliquot of 10pl from a glycerol stock of
these bacteria was inoculated into 5ml of prewarmed (37°C)
L-broth in a 30ml sterile universal. The culture was
incubated with shaking o/n at 37°C. From the o/n culture, 1ml
was inoculated into 100ml of prewarmed L-broth and was grown
to an O.D.™a of 0.6. This was reached in approximately 
600 g
2 hours and represents about 6 x 10 cells/ml.
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The cells were then spun down in chilled 30ml sterile 
plastic universals in an IEC Centra-7S benchtop centrifuge at 
3,500rpm for 10 minutes at 4°C. The supernatant was poured 
off and each of the pellets was gently resuspended in 25ml of 
ice-cold 10mM MgSC>4 and kept on ice for 30 minutes. The 
cells were spun down as above and each of the pellets was 
resuspended in 12.5ml of ice-cold 50mM CaCl2 and kept on ice 
for 15 minutes. The cells were finally spun down as above and 
each pellet was resuspended in 2rnl of ice-cold 50mM CaCl2. 
The pellets were pooled in one universal and stored at 4°C. 
The cells were used the day after they were made competent 
because the transformation efficiency increased six fold 
after being kept in the cold room o/n. After this the 
transformation efficiency decreased to the original level.
2.4.2 Preparation of Fragments for Subcloning
About 6pg of each bacteriophage DNA to be subcloned
were digested in a 40pl volume (described in section 2.6.1).
The reaction was stopped by addition of 5pl of 0.5M EDTA. 
This was followed by incubation at 70°C for 5 minutes. A 
20pl aliquot of this reaction was run on a mini-gel (BRL
"baby gel") to check that the DNA had been digested. If
digestion was complete, the remainder of the digest mixture 
was diluted to 50pl with sterile distilled water. Sodium 
acetate was added to 0.2M. This was then extracted with 25pl 
of phenol/chloroform until no interphase was seen.
(Note - the solution was not extracted with chloroform).
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Following phenol extraction, 3 volumes of cold absolute 
ethanol was added to the aqueous phase and this was incubated 
at -30°C for 30-45 minutes and then at -70°C for another 
hour. The DNA was spun down in a microcentrifuge and the 
pellet washed with 100% of cold absolute ethanol. The pellet 
was finally taken up in 20|il of sterile water. The DNA 
concentration was usually found to be approximately 150ng/pl. 
If not used immediately for ligation it was stored at -20°C.
2.4.3 Ligation
Plasmid pUCl9 (uncut and cut with Hind III) was 
commercially available from p & S Biochemicals. Ligations 
were performed in a lOpl volume containing lpl lOx ligase 
reaction buffer, lpl of O.lx T4 ligase (both available from 
the Amersham Ml3 cloning kit), lpl 10mM ATP, lpl 50mM DTT, 
(both from Sigma) and a volume of vector pUCl3 and digested 
DNA that would give approximately the same number of plasmid 
particles to recombinants. The reaction took place o/n at 
14°C.
2.4.4 Transformation
Flat bottomed sterile bijoux bottles were chilled on 
ice before use. Keeping the bijoux on ice, the ligation was 
mixed with ice-cold DNA buffer (lOmM Tris.HCl pH.7.5, lOmM 
CaCl2, lOmM MgCl2, filter sterilized) to a final volume of 
lOOpl. The buffer was then mixed with 200pl of competent 
cells and the mixture was kept on ice for 25 minutes,
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heat-shocked at 42° C for 2-3 minutes and kept at room 
temperature for 10 minutes. Prewarmed L-broth (0.7ml) was 
added to the above and incubated with shaking for 1 hour at 
37°C in the orbital shaker. About lOOpl of this mixture was 
spread on an Anp/X-Gal plate. The plates were left to 
incubate overnight and then stored at 4°C until colonies were 
picked.
The Amp/X-Gal plates were made as follows: 1.5% L-agar 
plates were made as normal. Ampicillin (Sigma, see general 
section) was added to the L-agar to a final concentration of 
lOOpl/ml when its temperature was no more than 45°C. The 
solution was mixed well and the plates poured before the 
L-agar started to solidify. When the plates were set, 40pl 
of X-Gal (Gibco BRL, see general section) was spread on the 
surface of the plate. The plates were incubated at 37°C for 
10 minutes until dry.
Three controls were carried out with every 
transformation:
(i) Competent cells were transformed with cut and religated
pUCl3 DNA to check the ligation procedure;
(ii) Competent cells were transformed with uncut pUCl3 DNA to 
estimate the maximum obtainable transformation 
efficiency;
(iii) Competent cells were taken through the transformation 
procedure with no transforming DNA added to ensure that 
the cells were not contaminated.
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2.4.5 Recombinant Selection
The bacterial host strain JM83, mentioned above, lacks 
part of the beta-galactosidase gene called lac Z and cannot 
synthesise this enzyme. This defect is complemented, however, 
by the presence of a lac Z' gene on the pUC series of 
vectors, including pUCl9 used here. Cloning into such 
plasmids involves insertional inactivation of the laz z' gene 
and recombinants are distinguished by their inability to 
synthesise beta-galactosidase. This is assayed during 
transformation by adding a lactose analogue, X-gal, which is 
broken down by beta-galactosidase to give a product which is 
deep blue in colour. If Xgal is added to the agar, along 
with ampicillin and an inducer of beta-galactosidase, such 
as isopropyl-thiogalactoside (IPTG)*, then non-recombinant 
colonies, the cells of which will synthesise 
beta-galactosidase, will be coloured blue. Recombinants with 
a disrupted lac Z' gene are unable to synthesise 
beta-galactosidase will therefore be white.
(* - N.B. E.coli stain JM83 are constitutive producers of
IPTG, so there is no need to add this to the agar for this 
bacterial strain).
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2.4.6 Picking Colonies and Small Scale Plasmid
DNA Preparation
White colonies were picked using sterile toothpicks 
and innoculated into 3ml of L-broth/Amp in a sterile plastic 
universal. These were incubated at 37°C o/n in an orbital 
shaker. From these cultures, 1.5ml was transferred into 
Eppendorf tubes and spun down in a microcentrifuge for 10 
minutes at room temperature. The cells were spun down and 
resuspended in 700pl of cold STET buffer (50mM Tris pH 8/0, 
50mM EDTA, 8% sucrose, 5% Triton X-100). To this, 50pl of 
fresh, cold lysozyme (lOmg/ml) was added and the tubes were 
left on ice for 5 minutes. They were then placed in boiling 
water for exactly 60 seconds and spun at full speed in the 
microcentrifuge for 20 minutes. The supernatant was 
transferred to a fresh Eppendorf tube and extracted with an 
equal volume of buffered saturated phenol/chloroform until no 
interphase could be seen. To the aqueous layer, sodium 
acetate (final concentration 0.2M) and isopropanol (0.6ml) 
were added. The tubes were then left for 30 minutes at -70°C, 
or o/n at -20°C. They were then spun down and the pellets 
washed in 95% cold ethanol. The tubes were inverted and left 
to drain on paper towels for 30 minutes. The DNA pellet was 
resuspended in 40pl of TE. Half of this was digested in a 
40|il reaction volume using the restriction enzyme Hind III to 
check whether the ligation had worked and the recombinant of 
interest had been subcloned.
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2.4.7 Large Scale Preparation of Plasmid DNA
To prepare a large amount of plasmid DNA, the method 
described above was simply scaled up. About 300ml of culture 
was routinely used. One extra step was added to this method 
by adding preboiled RNase to a concentration of 25|il/ml and 
incubating the mixture at 37°C for 60 minutes. This was 
followed by phenol extraction and ethanol precipitation.
2.4.8 Elution of DNA from Low Melting Point Agarose Gels
In order to isolate the insert from the plasmid DNA 
the following procedure was used. About 40;ag of DNA was 
digested with Hind III in an 800pl reaction volume. The 
digestion was run on a 1% low melting point agarose (BRL) 
gel. The gel was stained with ethidium bromide, destained and 
photographed. The required band was cut out with a wide blade 
scalpel and placed in a preweighed 30ml plastic tube. This 
was reweighed and the weight of the gel slice was calculated. 
An equal weight of water was added and this was heated at 
70°C to melt the agarose. This was incubated for at least 10 
minutes at 37°C. ice-cold phenol (saturated with 10mM 
Tris.HCl, pH7.5) was immediately added to it and the mixture 
vortexed. It was then spun in the Sorvall centrifuge using 
the SA 600 rotor, at 10K/4°C for 10 minutes. The supernatant 
was transferred to a fresh tube and the bottom layer was 
re-extracted after addition of an equal amount of sterile 
water. The samples were pooled and re-extracted until the 
interface was clear, to remove residual agarose. The aqueous
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phase was extracted with sequential equal volumes of 
butan-2-ol to remove phenol and reduce the volume to 
approximately 100-200pl. This was transferred to an-Eppendorf 
tube, \ volume of 7.5M ammonium acetate and 3 volumes of cold 
ethanol were added. The DNA was allowed to precipitate at 
-20°C o/n. The precipitate was spun down at 10K/4°C for 10 
minutes. The supernatant was removed and the pellet was 
washed with 100% cold ethanol and drained. Traces of ethanol 
were allowed to evaporate. The pellet was taken up in 
50-150pl of water depending on the size of the pellet. A 5(il 
aliquot of the DNA was run on a gel to check for purity and 
concentration. The remainder of the DNA was stored at -20°C.
2.4.9 Storage Conditions for Plasmid Recombinants
From the 3ml o/n culture 1.5ml was transferred to a 
sterile plastic bijoux, 1.5ml of glycerol was added, and they 
were inverted several times to mix the contents. These 50% 
glycerol stocks were stored at -20°C and were used to 
inoculate new cultures. Stabs were also made, as follows. 
L-agar (6%) was melted and ampicillin added as described 
above for making L-broth/Amp plates (section 2.4.4). About 
2-3ml of this was poured into sterile bijoux bottles and left 
to solidify. An overnight culture was grown by inoculating 
lOpl from the glycerol stock into 1ml of L-broth and 
incubating o/n at 37°C. A loopful was taken from this and 
stabbed into the medium in the vials, which were incubated at 
37°C o/n and stored at room temperature, in the dark.
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2.5 Culture and Preparation of Cells for DNA Extraction
2.5.1 Blood Samples (modified from Kunkel et.al. 1977)
Peripheral blood (5-25ml) was collected in 30ml
sterile plastic universals containing 2ml of a 4.5% EDTA/
0.7% NaCl solution. The bottles were inverted several times 
to ensure that the blood and EDTA solution were thouroughly 
mixed, as insufficient mixing could lead to coagulation of
the blood, rendering the samples almost useless for the 
extraction of DNA. If the blood samples were not used for DNA 
extraction immediately, they were stored at -20°C. The 
samples were thawed when required by leaving them at room 
temperature for 2-3 hours. They were then mixed with 
5 volumes of cold lysis buffer (0.32M sucrose, lOmM 
Tris.HCl, PH7.5, 5mM MgCl2, 1% Triton X-100 (v/v)) and spun 
for 10 minutes at 6k,4°C in a Sorvall RC-5B centifuge, using 
an HS-4 rotor. The supernatant was removed and the pelleted 
nuclei were used for DNA extraction.
2.5.2 Lymphoblastoid Cell Lines
Established lymphoblastoid cell lines, transformed 
with Epstein-Barr virus, were grown in HAMS FlO (Gibco) + 10% 
fetal calf serum + 10% new born fetal calf serum +
1% penicillin/streptomycin (Gibco). When the culture reached 
about 10^ cells, it was spun down; the cells were resuspended 
and washed in saline to remove any traces of serum.
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2.5.3 Hybrid Cell Lines and Fibroblast Cell Lines
Fibroblast cells were grown in culture bottles in the
same medium as for lymphoblastoid cell lines, until the 
monolayer was confluent. The cells were then trypsinised, 
tranferred to 30ml sterile universals and centrifuged at 
10,000 rpm three times, washing with saline between spins.
2.5.4 DNA Extraction
The pelleted nuclei from the blood samples or the 
washed pellets from the cell lines desribed above were 
resuspended in 4.5ml of 0.075M NaCl/0.024M EDTA, pH8.0. 
Proteinase K (lOOpl) and 10% SDS (250^ 1) were added and the 
mixture was incubated at 37°C overnight, with gentle shaking. 
The sample was then transferred to a 13ml plastic tube and an 
equal volume of phenol/chloroform was added. This was mixed 
by inversion for 10 minutes and then spun at 10k for 10 
minutes in a Sorvall RC-5B centrifuge, SM24 rotor at 25°C. 
The aqueous layer was transferred to a clean tube and the 
phenol extraction was repeated until the interface was clear 
of protein or other impurities. This usually involved 2 or 3 
phenol extractions. An equal volume of chloroform was then 
added to the aqueous layer. The sample was again mixed and 
centrifuged under the same conditions. The final aqueous 
layer was transferred to a sterile 30ml plastic universal. 
Sodium acetate was added to a final concentration of 0.3M, 
and then 2 volumes of cold 100% ethanol were added to the 
mixture. Following inversion of the tube, the DNA
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precipitated, and was "spooled out" using a glass Pasteur 
pipette with a heat-sealed end. The DNA was resuspended in 
TE buffer by gentle shaking over a period of 2 days at 4°C. 
The DNA was subsequently stored at 4°C.
2.5.5 Estimation of DNA Concentration
The concentration of the DNA samples was calculated by 
measuring the optical density at 260nm in a spectrophotometer 
(LKB or Pye/Unicam) as follows. A 10pl aliquot of the DNA was 
added to 990pl of TE buffer in an 1.5ml Eppendorf tube and 
mixed thoroughly by vortexing. The spectrophotometer was 
"zeroed" by measuring the O.D.^q of 1ml of TE in a quartz 
cuvette (Pye/Unicam). Since 1 O.D.^q unit corresponds to 
50|jg of DNA, and because the DNA was diluted by a factor of 
100, the O.D.26q reading of the DNA sample was multiplied by 
5000 to give the concentration in (jg/ml.
2.5.6 DNA and mRNA Preparation from Foetal Liver
The tissue was removed and frozen immediately in 
liquid nitrogen, in order to prevent degradation of the 
nucleic acids present. The tissue was removed from liquid 
nitrogen and broken up into small pieces, then crushed to a 
powder and added to an appropriate volume depending on the 
size of the sample (typically 500ml) of guanidine thiocyanate 
solution (5M guanidine thiocyanate, 50M Tris pH7, 50mM EDTA, 
5% beta-mercaptoethanol, sterilised by filtration). The 
mixture was shaken gently to dissolve the powdered tissue and
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20% Sarcosyl was added to 0.2% final concentration. Both 
these chemicals prevent degradation of the tissue. The 
RNA/DNA was then prepared by ultra-centrifugation (Sorvall 
OTD-65 Ultra Centrifuge, AH627 swing out rotor) for 48-72 
hours at 25K/25°C in a CsCl gradient. The correct gradient 
was achieved by adding 4.3ml of CsCl suspension (5.7M CsCl, 
50mM EDTA, pH7) to 17ml polyallomer tubes.
After centrifugation, the DNA was collected (top layer) 
from the CsCl gradient, using a plastic pipette and was 
transferred to 30ml tubes where it was precipitated with 4-5 
volumes of cold 70% ethanol. The DNA was spooled out using a 
heat-sealed Pasteur pipette and was resuspended in 0.075M 
NaCl, 0.024M EDTA, pH8.0, the volume depending on the size of 
the DNA pellet. Proteinase K (to 100(jg/ml) and 10% SDS (to 
0.5%) were added and this was. incubated overnight at 37°C. 
The DNA was phenol and chloroform extracted (as described for 
blood samples) and precipitated with 0.3M sodium acetate and 
absolute ethanol. The pellet was washed in 70% ethanol, 
resuspended in TE (volume depending on size of the pellet) 
and finally stored at 4°C.
The RNA formed a translucent pellet at the bottom of 
the centrifuge tube. Approximately lOOpl of filtered 8M urea 
was added and the pellet was resuspended using a 200(jl 
Pipetman. Additional 8M urea was used if required. The 
suspension was transferred to Eppendorf tubes and 2 volumes 
of 4M Lithium Chloride was added to each tube. These were 
left at 4°C for several days to allow precipitation of the
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RNA. It was then pelleted and resuspended in sterile 
distilled water. Sodium acetate to a final concentration of 
0.3M and 2 volumes of 100% ethanol was added, the resultant 
suspension was then stored at 4°C.
2.5.7 Isolation of poly(A)+RNA
When ready to isolate poly(A)+ RNA (i.e. mRNA), the 
RNA was pelleted, dried, dissolved in warm (37°C) elution 
buffer (lOmM Tris, pH7.5, 0.2%SDS). An oligo (dT) column was 
prepared by resuspending oligo(dT) cellulose in elution 
buffer and the column was poured in a Bio Rad glass column 
(11cm long). This was washed with 10ml of warm elution buffer 
and equilibrated in about 10ml of binding buffer (elution 
buffer + 0.4M Nad). Nad was also added to the RNA to a
final concentration of 0.4M and the RNA was passed through 
the column. The effluent was collected and passed through the 
column twice more, to ensure that all the poly(A)+ RNA was 
bound to the column, and finally collected in a poly A tube. 
The column was washed with 3ml of binding buffer and 
collected into the poly A tube. The poly (A)+ RNA was eluted 
by passing 5 x 1ml of warm elution buffer through the column 
and collecting it in the poly (A)+ tube. The column was washed 
with 3ml of binding buffer, which was also collected in the 
poly (A)+ tube. The poly A- was again added to the column and 
passed over three times, so that any remaining poly A RNA
would be bound to the column. This was eluted by washing the
column with warm elution buffer. A tenth volume of 4M NaCl
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was added to the poly A+ mixture and the binding and elution 
procedure was repeated once more. The final elution was done 
with 8ml of warm elution buffer. The O.D.26Q of a 1ml aliquot 
of the poly A+ mixture was measured in order to find the 
concentration. It was then lyophilised to approximately 4ml 
final volume. The RNA was ethanol precipitated and stored at 
-20°C. When required, a small aliquot was resuspended for 
reverse transcription, as described in Section 2.6.4.
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2.6____ Recombinant DNA Techniques
2.6.1 Restriction Enzyme Digestion
The basic digestion reaction was carried out in a 
30pl volume which contained 4|il of lOx core buffer (BRL)*,
2pl of O.lM spermidine, 2^1 of the appropriate restriction 
enzyme (usually at 10 units/pl), and an appropriate volume of 
sterile distilled water, depending on the concentration of 
the DNA sample. Spermidine (Sigma) was used to improve the 
digestion of the DNA samples (see Bouche 1981). The amounts 
of DNA digested were typically 6pg from genomic samples, 
10-15/g of DNA from hybrid cell lines and variable amounts 
for plasmids or bacteriophage clones, depending on their 
subsequent use. Digestions of genomic DNA samples and hybrid 
DNA samples were performed o/n at the required temperature 
for each enzyme in small Eppendorf tubes. Digests of plasmid 
or bacteriophage DNA were usually performed for 3-4 hours. 
Reactions were terminated by the addition of 5^ 1 of "Stop" 
mix (50mM EDTA, 50% glycerol, 2% Ficoll, and 50|ag/ml 
Orange G ). Digested DNA samples were immediately loaded onto 
agarose gels, or sometimes stored at -20°C until further use. 
(As full listings of restriction enzyme recognition sites and 
reaction conditions are available elsewhere (Maniatis et al. 
1982, for example), these are not presented here).
( - Although most manufacturers supply specific buffers for
use with their restriction enzymes, this buffer was found to 
give good results with all enzymes tested)
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The choice of restriction enzymes for RFLP screening 
of recombinant probes (Results, Section 3.3) was largely 
dictated by consideration of the availability and cost of the 
different enzymes. Enzymes containing the CpG doublet in 
their recognition site have been shown to reveal RFLPs at a 
higher frequency than many other enzymes (Skolnick & White 
1982) and as such the enzymes Tag I and Msp I were also 
included in the present study.
2.6.2 Gel Electrophoresis
Electrophoresis was carried out in 0.8% agarose 
(Sigma) gels in "E buffer" (see general section). Perspex 
electrophoresis tanks were prepared to our design perspex by 
a local supplier. LKB "Bromma/2197 constant power supply" 
power packs were used, typically at 200mA/3-4 hours for the 
10cm x 13cm gels used. Following electrophoresis, gels were 
stained for 10 minutes in "E buffer" containing ethidium 
bromide (Sigma; final concentration lug/ml). The DNA was 
visualised on a UV transilluminator (UVP inc.) and 
photographed using a Polaroid CU-5 land camera fitted with a 
red filter, and a black and white Polaroid type 667 film.
2.6.3 Southern Blotting
After photographing the gel, it was treated with
0.25M HCl for 15 minutes to partially depurinate the DNA (see 
§Wahl et al. 1979). This was followed by two successive 
20 minute periods in denaturing solution (0.5M NaOH, 1.5M
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NaCl) and two 20 minute washes in neutralising solution (0.5M 
Tris.HCl pK 7.4, 3M NaCl). The DNA was transferred to a 
nylon membrane (Hybond-N, Amersham) in 20xSSC, as described 
by Southern (1975). After 16-24 hours the filter was removed 
from the gel, washed in 2 x SSC, blotted dry and baked in an 
oven at 80°C for 5 hours.
2.6.4 Preparation of Radiolabelled Probes
1 ._____Nick Translation (from Rigby et al 1977)
In some cases, DNA probes were labelled by nick 
translation using the Amersham nick translation kit. The 
reaction was performed in a 50^1 volume. About 0.5|ig of DNA 
was radiolabelled to a specific activity ranging from 15 to 
85 x 10 cpm/pg. The details of the method are as follows.
DNA was dissolved in a,5x buffer (Amersham nick 
translation kit) and water, when necessary. DNA polymerase 
(2|il) (also included in the kit) and 50pCi of 
[alpha-3 2P]-dCTP (Amersham, 3000Ci/mmol) were added to each 
reaction. The reaction was incubated at 14-15°C for one hour. 
Labelled DNA was separated from unincorporated nucleotides by 
passage through a Sephadex G-50 column (medium type, 
Pharmacia; 9cm glass columns from Bio Rad), equilibrated 
with 1 x SSC, 0.1% SDS. The radiolabelled probe was collected 
as the first peak to emerge form the column. An aliquot was 
counted on an LKB 1215 Rackbeta liquid scintillation counter 
to allow the specific activity to be calculated.
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2 . Oligonucleotide Labelling (Feinberg & Vogelstein 1983)
The advantages of this method over nick translation 
are (i) it can be used to label DNA samples which are impure 
or at low concentration, and (ii) it can be used to label DNA 
cut from low melting point gels without prior elution.
Details of the reagents used are as follows :
Oligo reaction mix
Firstly, the following four solutions are made, up:
Solution A: Solution B:
1.25M Tris.HCl pH8.0 1ml Solution A
0.125M MgCl2 18pl beta-mercapto-ethanol
5|Jl dATP, dGTP, dTTP 
Solution C: (each of these dissolved
2M Hepes, pH6.6 in TE at lOOmM)
Solution D:
Hexadeoxyribonucleotides (Pharmacia, PL No. 2166) 
at 90 O.D. units per ml.
Solutions B, C and D are then mixed in the ratio 100:250:150 
to give lOx reaction mix. Pure DNA samples were diluted to 
50ng/pl for oligo-labelling, while for DNA/agarose samples, 
the fragment to be labelled was excised from LMP agarose, 
diluted with twice the weight of sterile water, and 20|il of 
this mixture was added to the reaction. DNA from either
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source was boiled for 10 minutes, and then incubated at 37°c 
for at least another 10 minutes. This was mixed with lOpl of 
reaction mix (see below), 2pl of nuclease-free BSA (lOmg/ml 
from Sigma), lpl of Klenow fragment (Amersham), 2pl of 
[alpha-3 2P]-dCTP (Amersham, (3000Ci/mmol) and 5pl of sterile 
water. The reaction was incubated at room temperature o/n, 
and then terminated by the additon of 50pl of stop mix (20mM 
NaCl, 20mM Tris.Cl pH7.5, 2mM EDTA, 0.25% SDS). As with nick 
translation, the DNA was separated from the unincorporated 
nucleotides on a G-50 Sephadex column.
3j Reverse Transcription of mRNA to cDNA
To prepare radiolabelled cDNA, 4-5pg of mRNA in 
ethanol was used. The RNA was spun down in an Eppendorf 
microcentrifuge for 5 minutes at full speed. The supernatant 
was discarded and the pellet was left to drain. It was then 
washed in 100% alcohol, spun down, again left to drain and 
put in an 80°C oven for 1-2 minutes to dry. The RNA was then
resuspended in 32pl of water and heat-denatured for 5 minutes
at 70°C. It was cooled on ice and spun down briefly before 
the addition of : 5pl lM Tris.HCl pH8.3, 1.3(jil 3M KCl, lOpl 
0.1M MgCl2, 4pl 0.25M beta-mercaptoethanol (Sigma), 4jal of 
lmg/ml oligo(dT) (P-L Biochemicals, Inc.) in H20, 4.8pl of 
deoxyadenosine, deoxyguanosine and deoxythymidine (all at 
20mM,'from Sigma), 25pl of lmg/ml Actinomycin D (Sigma), 8pl 
[alpha-32P]-dCTP (3000Ci/mmol, Amersham) and 2 pi of reverse 
transcriptase (10 units/pl, Anglian Biotechnology). These
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were mixed well and incubated for 1 hour at 37°C. The 
reaction was stopped by addition of 40pl of 0.5M EDTA and 
30pl of 2N NaOH, was mixed well and incubated for 2 hours at 
42°C. This was run through a long (18cm) G-50 Sephadex column 
equilibrated with 1 x SCC, 0.1% SDS. The radiolabelled cDNA 
was collected and its specific activity measured as described 
above. This was usually around 12 - 15 x 10 cpm/pg.
2.6.5 Hybridisation, Washing Conditions and Autoradiography
1 ._____ Pr ehy br idisation
Filters were prehybridised in 50% formamide 
(deionised), 5 x Denhardts (see general section), 5 x SCC 
(see general section), 50mM sodium phophate pH 6.8, 380pg/ml 
sonicated, denatured salmon sperm DNA, lOpg/ml Poly (A),
0.2% SDS. Filters were typically incubated at 42°C o/n, but 
sometimes for shorter periods of time, for example 3-4 hours.
2  ._____ Hybridisation
The radiolabelled probe was denatured by boiling for 
10 minutes and then added to 5-10ml of hybridisation buffer 
(50% Formamide, 1 x Denhardts (see general section), 5 x SSC, 
20mM sodium phosphate pH6.8, lOOpg/ml salmon sperm DNA, 
20pg/ml Poly (A) (Boeringer), 10% dextran sulphate (Sigma).
The prehybridisation buffer was discarded and the 
hybridsation buffer with the probe was added to the filter.
The bag was re-sealed and incubated at 42°C o/n.
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3h Post-hybridisation washing
After hybridisation, the filter was removed from the 
bag and washed at room temperature in 2 x SSC. Filters used 
for screening of the library with cDNA and genomic DNA were 
washed in 2 x SSC, 0.1% SDS twice for 10 minutes at room 
temperature and afterwards in 1 x SSC, 0.1% SDS for 20 
minutes at 42°C. The filters were then monitored using a 
mini-monitor (GM Instruments) and if necessary, were washed 
down to 0.5 x SSC, 0.1% SDS.
Filters used for Southern blotting of genomic or 
hybrid DNA were washed in 2 x SSC, 0.1% SDS twice for 
10 minutes at room temperature, and then in 0.5 x SSC for 
20-30 minutes at 65°C. Again, if the background sounded quite 
radioactive after monitoring (over 10 counts per second, for 
example), the filter was further washed with 0.1 x SSC,
0.1% SDS at 65°C.
4.  Autoradiography
Filters were placed between sheets of polythene and 
exposed to Kodak X-ray film between intensifying screens in 
Dupont Cronex X-ray cassettes. The films used were X-Omat S 
and X-Omat XAR-5. Exposure times varied from a few hours to 
weeks. The films were developed in a Fuji RG II X-Ray Film 
Processor, using Kodak X-Omat developer and fixer.
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5_._____ Removal of radiolabelled probes from filters
One of the advantages of using Hybond-N membrane for 
Southern blotting is that the radiolabelled probe can be 
removed efficiently and the filter can be reprobed a number 
of times with different probes. The procedure for removal of 
probes is as follows.
Filters were washed in 0.4M NaOH for 30 minutes at 
45°C and for 30 minutes in neutralising solution (as used for 
Southern blotting). They were then rinsed in 1 x SSC,
0.1% SDS and placed in heat-sealed bags prior to further 
prehybridisation and hybridisation. The efficiency of the 
removal process was checked by exposing the stripped filters 
to X-ray film.
6. Pre-reassociation of Repeated Sequences from
Hybridisation Probes (from Sealy et al 1985)
The method described previously (section 2.5.6) for 
isolating DNA from fetal tissues produces large amounts of 
genomic DNA (routinely, about 10 - 30mg). This was mainly 
used for preassociation experiments, in which the repeated 
sequences from radiolabelled probes were "competed out" by 
pre-reassociation with large amounts of unlabelled, sonicated 
genomic DNA. Following preparation of the DNA, it was 
subjected to 15 sonic bursts of 5 seconds, with 15 second 
intervals on ice in between, using a Soniprep 150 MSE
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sonicator. The DNA was ethanol-sodium acetate precipitated as 
described previously and was left at -30°C o/n. The DNA was 
spun down to a pellet and resuspended in TE buffer to a 
concentration of lOmg/ml. The following were added in a 1ml 
reaction volume : 125pl of 30 x SSC, 5mg of the sonicated 
genomic DNA in a volume of 500pl and the radioactive probe. 
The volume was made up to 1ml with TE. The radiolabelled 
probe was mixed with the sonicated DNA and the salt and was 
denatured in boiling water for 10 minutes. It was then cooled 
on ice for 1-2 minutes before incubation for 20 minutes in a 
68°C waterbath. The probe was then added to the prewarmed 
hybridisation mixture and was applied to the filter. The rest 
of the hybridisation and washing conditions were as described 
above.
2.6.6 Sizing of DNA Fragments
In order to determine the sizes of DNA fragments 
detected by certain probes in Southern blot experiments, the 
following procedure was used. Genomic DNA samples were run on 
0.8% agarose gels as normal, but in one of the lanes of the 
gel, a set of size markers was added. The markers used were 
available commercially (BRL) and were roughly multiples of 
lkb, and ranged in size from lkb to 12kb. Following 
electrophoresis, the gel was photographed with a ruler next 
to it. The distances migrated by fragments of a specific 
length were noted, and a standard line was drawn on 
logarithmic graph paper. After Southern blotting,
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hybridisation and autoradiography of the filter, the 
distances migrated by the fragments were compared with the 
line graph, and the fragment lengths calculated.
CHAPTER THREE
RESULTS
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3. 1____ isolation of Recombinants from the Flow-Sorted
Chromosome 21-Specific Library of Young et al (1983)
Following extensive screening and purification in 
order to isolate single-copy, expressed sequences, (see 
Materials & Methods, Section 2.3.7), six recombinant 
bacteriophage were analysed : J21.1, J21.2, J21.3, J21.4,
J21.5 and J21.6. DNA was prepared from each, digested with 
the restriction enzyme Eco RI to release any DNA inserts they 
might contain and separated by agarose gel electrophoresis. 
The results of this are shown in Figure 1 and the sizes of 
the human DNA inserts are given in Table 1.
3.1.1 Regional Mapping of Recombinants
The human DNA inserts contained in these clones were 
radioactively labelled using the random priming method 
(Feinberg & Vogelstein 1983) and then hybridised to Southern 
blots of DNA from the panel of somatic cell hybrids, normal 
and trisomy 21 individuals illustrated schematically in 
Figure 2. Although the screening procedure used was intended 
to select for single-copy sequences, it became obvious when 
these clones were hybridised to this mapping panel that each 
of them contained a repetitive DNA element, as might be 
expected for inserts of this size. All six gave an similar 
"smear" pattern of hybridisation; representative results are 
shown in Figure 3 for clones J21.1 and J21.2.
2 3 4* 5 6 Ladder
bacteriophage, 
cloning awv\y *
(21.7 kb and 14.2 kb')
P o ll ow in g  
Page 1°)
Figure 1 : Ethidium bromide-stained agarose gel showing
Eco RI digestion of recombinants isolated from 
the flow-sorted chromosome 21 library of Young 
et al. (1983).
Lane numbers correspond to the J21 clone 
numbers (for example lane 1 contains DNA from 
J21.1, lane 2 from J21.2 etc.). The last lane 
on the right contains 1 kb ladder (BRL) as a 
size marker. The sizes (in kb) of the largest 
fragments are indicated to the right of the 
photograph.
Clone Insert
Size (kb)
J21.1 9.5
J21.2 13.5
J21.3 11.0
J21.4 10.0
J21.5 12.0
J21.6 11.5
Table 1 : insert sizes of recombinants isolated
from the sorted chromosome 21 library 
of Young et al (1983).
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Figure 3 : Autoradiographs showing hybridisation of Prob^  
J21.1 and J21.2 to the 9-member hybrid mapping
panel shown in Figure 2.
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3.1.2 Identification of Clones containing Single-Copy
DNA Sequences
To test the possibility that these clones might also 
contain single-copy sequences, the pre-reassociation 
technique described by Sealy et al (1985) was used (details 
given in Materials & Methods, Section 2.6.5). This was 
initially attempted with clones J21.1 and J21.2 and the 
results are shown in Figure 4.
In Figure 4(a), a clear signal can be seen in all 
lanes of the panel except 3, 4 and 5. There is also a 
greater intensity of hybridisation to the DNA from trisomy 21 
patients (lanes 8,9) compared to normal individuals (lanes 
6,7). This indicates that clone J21.1 does contain a single 
copy sequence from chromosome 21, which naps in the region 
21q22.1 - 21qter.
In Figure 4(b), two strong bands of hybridisation and 
two weaker signals can be seen in lanes 6 to 9 of the panel. 
None of these hybridisation signals appear in any of the 
other DNAs in the panel. There is also no difference in the 
intensity of hybridisation between normal and trisomy 21 
individuals. This result demonstrates that there is a single- 
or low-copy number sequence within clone J21.2 which does not 
originate from chromosome 21. It should also be noted that 
there is no difference in hybridisation pattern or intensity 
between the DNAs from males and females on the panel, which 
suggests that these bands are not due to hybridisation to 
either of the sex chromosomes.
Figure 4 : Autoradiographs showing hybridisation of 
probes J21.1 and J21.2 to the 9-member 
hybrid mapping panel shown in Figure 2 
following pre-reassociation of the probes 
with unlabelled human genomic DNA.
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3.1.3 Attempted Isolation of Single-Copy Sequences from
Clone J21.1
An attempt was made to separate the single-copy 
chromosome 21-specific sequence from the repetitive DNA also 
present in clone J21.1. The method used involved the 
following steps : 1. Digestion of clone J21.1 with a range 
of restriction enzymes, each used in combination with Eco RI, 
the enzyme originally used to construct the recombinant 
library; 2. Preparation of duplicate Southern blots for each 
digestion following separation on 0.8% agarose gels; 3. 
Hybridisation of one of the filters with radioactively 
labelled total human genomic DNA to identify 
weakly-hybridising fragments which may represent low- or 
single-copy sequences. The duplicate filter was probed with 
bacteriophage lambda DNA to identify fragments generated from 
the vector and so eliminate these from further analysis.
DNA from clone J21.1 was digested with those enzymes 
which generated the putative low-copy number fragments. 
Following electrophoresis on a 1% LMP agarose (BRL) gel, 
these fragments were excised from the gel, labelled by the 
random primer method and hybridised to the same panel of DNAs 
used before (Figure 2). Unfortunately all fragments gave a 
"smear” pattern similar to those shown in Figure 3 and 
typical of repetitive DNA hybridisation. Due to the lack of 
success in isolating any single-copy chromosome 21-specific 
DNA sequences from clones J21.1 and J21.2, no further 
analysis of clones J21.3 to J21.6 was performed.
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3.2 isolation of Recombinant Clones from the Chromosome 
21-Specific Flow-Sorted Library Supplied by the 
National Gene Library Project (Lawrence Livermore 
Laboratory)
The main objective of the screening procedure used to 
isolate recombinant clones from this libary was to identify 
plaques which showed a lack of hybridisation with labelled 
total genomic DNA in the hope that these would contain low- 
or single-copy sequences. From the initial plating out of the 
library, involving approximately 4000 plaques, a total of 480 
putative single-copy plaques were picked.
3.2.1 Restriction Enzyme Digestion of Recombinant Clones
DNA was prepared from 120 of the 480 plaques and 
digested with the restriction enzyme Hind III, which was used 
in the original construction of this recombinant library. 
Following separation of the resulting fragments separated on 
agarose gels, it was determined that 23 of the 120 purified 
bacteriophage plaques contained DNA inserts. The approximate 
lengths of these are listed in Table 2.
Following 
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Clone Insert 
Size (kb)
Clone Insert 
Size (kb)
JG12 4.1 JG81 5.0
JG21 3.2 JG83 5.0
JG22 1.7 JG87 2.7
JG24 4.3 JG88 6.0
JG51 4.7 JG90 5.0
JG61 2.9 JG93 4.0
JG62 2.0 JG95 4.2
JG63 2.3 JG99 2.7
JG68 4.2 JG101 3.2
JG72 3.2 JG108 3.2
JG73 3.0 JG373 4.1
JG77 1.8
Table 2 - Insert sizes of recombinants isolated from the
Lawrence Livermore flow-sorted chromosome 21 
library, following Hind III digestion.
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3.2.2 Identification of Recombinants Containing Single-Copy
DNA sequences
All DNA inserts were tested to determine whether or
not they were single-copy before hybridising them to the
hybrid panel mapping filters. For this, "reptest" filters 
were prepared which contained DNA from one normal human, one 
trisomy 21 patient and from the hybrid cell line THYB133R, 
which contains chromosome 21 as its only detectable human 
chromosome. The results of hybridising the probes listed in 
Table 2 to these filters are shown in Figure 5.
It became clear that several of the cloned inserts
contained repetitive sequences, as they showed typical 
"smear" patterns of hybridisation on all three DNA samples. 
Given the high degree of similarity between the hybridisation 
patterns of these clones, only one example of this type is 
shown in Figure 5, for clone JG61. The other repetitive 
inserts were JG68, JG83, JG87, JG88, JG93, JG95 and JG101, 
and no further analysis of these clones was performed.
Clones JG51 and JG73 were at first thought to contain 
highly repetitive sequences, but closer inspection revealed 
several distinct bands of hybridisation at the lower end of 
the filters. Although hybridisation to the 21-only hybrid was 
not very clear, it was decided that these probes should be 
investigated further.
■ All other probes detect a single hybridisation band in 
each of the three DNA samples, indicating that these are 
single-copy sequences derived from chromosome 21.
Foilowin
3
N T H  N T H  N T H
JG72 JG77 JG81
Figure 5 : Autoradiographs showing hybridisation of 
probes listed in Table 2 to "Reptest" 
filters (see text, section 3.2.2).
N : Normal Human Genomic DNA
T : Trisomy 21 Genomic DNA
H : Chromosome 21-only Hybrid Cell Line
N T H
JC-90
N T H
JG61
N T H
N T H
JG99
N T H
JG108
N T H N
JG51 JG73
Figure 5 : Autoradiographs showing
hybridisation of probes listed in 
Table 2 to "Reptest" filters (see 
text, section 3.2.2).
N : Normal Human Genomic DNA 
T : Trisomy 21 Genomic DMA 
H : Chromosome 21-only Hybrid
JG373
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3.2.3 Regional Mapping of Recombinant Clones
All single- and low-copy number sequences were 
hybridised to a hybrid mapping panel simliar to that shown in 
Figure 2. Some changes were made in the DNA samples used, 
resulting in the panel shown in Figure 6. Using this panel, 
it is possible to localise DNA probes into one of three 
chromosomal regions, as illustrated in Figure 7(a). DNA was 
subsequently obtained from a further set of six hybrid cell 
lines containing various parts of chromosome 21. The 
inclusion of these samples in the mapping panel greatly 
increased the accuracy with which it was possible to localise 
DNA sequences, as shown in Figure 7(b). The hybrid panel 
incuding these additional samples is shown in Figure 8. To 
simplify matters the panels shown in Figures 6 and 8 will be 
referred to as "Panel 6" and "Panel 8", respectively. 
(Further details on hybrid cell lines are given in Section
2.2 of Materials & Methods).
For use in Southern blots experiments, hybrid panel DNA 
samples were digested with the restriction enzyme Hind III. 
As this was the enzyme originally used in the construction of 
the library, none of the cloned inserts should contain 
recognition sites for this enzyme and should therefore show a 
single hybridisation signal in each DNA sample.
Due to the multiple-band patterns observed with JG51 
and JG73, results on the hybridisation of these probes to the 
mapping panels are considered separately from the other, 
single-copy probes.
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3.2.4 Single-Copy Probes - Hybridisation to Panel 6
The hybridisation patterns of the single-copy probes 
to this panel are shown in Figure 9 and the following 
information can be derived from these :
(a) JG12, JG22, JG24, JG63, JG77, JG81, JG108 and JG373 all 
show a similar band pattern on this panel - the only lanes to 
which these probes do not hybridise are tracks 3 and 7. This 
allows the regional localisation of these sequences to the 
region of chromosome 21 not present in the hybrid line 
AHVI-17, which is 21q22.1 - 21qter;
(b) JG21, JG62, JG72, JG90 and JG99 hybridise to all members 
of the panel except mouse DNA. It can be deduced from this 
that these probes map in the region of overlap between 
hybrids AIWBf2 (lane 2) and AHVI-17 (lane 3), which is 
defined cytogenetically as 21q21-21q22.1.
By comparing the relative intensities of hybridisation 
signal within each panel it is apparent that despite efforts 
to ensure that equal amounts of DNA were added to each track 
of these gels/filters, this had not been achieved. As a 
result of this it was decided that no conclusions on the 
regional localisation of DNA sequences could be drawn from 
differences in dosage of hybridisation signal, for example 
between TrD2 and normal human DNA, as had originally been 
hoped. It would still be possible, however, to localise 
probes using only positive/negative hybridisation criteria.
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3.2.5 Single-Copy Probes - Hybridisation to Panel 8
Unfortunately, time did not permit the hybridisation 
of all single-copy probes to this panel. Results are shown in 
Figure 10 for probes JG21, JG72, and JG90. These three probes 
show the same pattern of hybridisation on this panel - that 
is, they hybridise to all lanes except 7, 9, 10 and 11. This 
confirms the mapping of these sequences to 21q21 - 21q22.1
and moves the lower limit of this region to a slightly more 
proximal location, as defined by hybrid ACEM2-90 (lane 9).
Probe JG77 (also shown in Figure 10) hybridises to all 
lanes of the panel except 6, 7, 10 and 11. This probe can 
therefore be mapped in the region of chromosome 21 missing 
from hybrids AHVI-17 (lane 6) and 8q- (lane 7), which is 
defined cytogenetically as 21q22.1 - 21q22.2.
Probe JG373 was hybridised to a slightly different 
panel of hybrids, outlined in Figure 11. The hybridisation 
pattern (also shown in Figure 11) allows the localisation of 
this sequence to a small region close to the telomere of 
chromosome 21, in the distal part of band 21q22.3. This is 
based on its lack of hybridisation to hybrids R2-10 (lane 1) 
and HD-4 (lane 6).
ro llo w m q  I'age,
I 2  3  4  ^  6  7 8 ^  10 I I  12. 13
• t
JCiZl
2 3  4 - 5  6 7 8 ^  10 H 12 13
JO 72
2 3 4 5 6 7 8 9 10 I I 12 13
J090
2 3 4  5 6 7 8 10 II 12 13
M  ^  -B ^  »
J077
Figure 10 : Autoradiographs showing hybridisation of 
single-copy probes to mappping panel 8.
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3.2.6 Mild Repeat Probes - Hybridisation to Panel 6
Using Normal (10cm long) Gels
Probes JG51 and JG73 show a similar and intriguing 
pattern of hybridisation on this mapping panel (Figure 12). 
Both probes detect a regular "ladder" of bands on these 
filters, suggesting that they are homologous with a series of 
mildly repetitive sequences. There are also numerous bands 
present in the genomic DNAs of the panel which do not appear 
in the DNA of hybrid THYB133R (lane 1), which suggests that 
these probes detect homology with sequences on chromosomes 
other than 21.
It was originally intended that regional localisation 
of these probes should be carried out using this panel of 
hybrids, as for the single-copy probes. The fact that JG51 
and JG73 detect homology with non-chromosome 21 sequences 
complicates this, however. Since only THYB133R can be said to 
contain no other human chromosomes apart from 21 (see 
Materials & Methods, Section 2.2), it would be impossible to 
tell whether or not hybridisation to the DNA of the other 
hybrids was due to homology with sequences on chromosome 21. 
No conclusions regarding the regional localisation of these 
two probes could be drawn from the hybridisation to this 
panel of DNAs.
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3.2.7 Mild Repeat Probes - Hybridisation to Panel 6
Using Longer Gels
Due to the multiple-band hybridisation patterns found 
with probes JG51 and JG73, and the difficulties in resolving 
these bands on the normal (10cm long) gels, further analysis 
of these probes was carried out using longer (20cm) gels. As 
mentioned above, regional localisation of sequences detected 
by these probes is not possible using the hybrids in panel 6. 
Some conclusions can still be drawn from their hybridisation 
patterns, however, as follows.
Probe JG51
The result of hybridising probe JG51 to mapping 
panel 6 on a long gel is shown in Figure 13a. The filter
shown was washed at higher than normal stringency of 
post-hybridisation washing. Under these conditions, only one 
band is visible in lane 1, which contains DNA from the 
21-only hybrid THYB133R. This band is approximately 4.7kb in
length and is therefore likely to represent the original
sequence on chromosome 21 from which JG51 was cloned.
The large number of bands present in the genomic DNAs 
of the panel, even at this high stringency, suggests that
sequences homologous to JG51 are dispersed throughout the 
human genome.
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Probe JG73
Figure 13b shows the hybridisation of probe JG73 to 
the same DNA samples under the same conditions, it is 
possible to see at least 4 bands in lane 1. The lowest band 
is the strongest in terms of signal intensity, and was found 
to be 3.0kb in length. This band is therefore likely to be 
due to hybridisation to the original JG73 sequence on 
chromosome 21. Although the bands are less distinct in this 
autoradiograph, it is also possible to state that JG73 also 
detects homology with numerous non-chromosome 21 sequences in 
the human genome.
In summary, therefore, probes JG51 and JG73 were 
isolated independantly from the same chromosome 21 
recombinant library and have insert sizes of 4.7 and 3.0kb, 
respectively. Each contains a mildly repetitive sequence 
which detects homology with numerous DNA sequences in the 
human genome, both on chromosome 21 and on other chromosomes.
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3.2.8 Mild Repeat Probes - Hybridisation to Panel 8
Probes JG51 and JG73 were also hybridised to mapping 
panel 8, using the 20cm long gels (Figure 14). With the 
exception of hybrids AHVI-17 (lane 6), AIWBf2 (lane 8), and 
8q- (lane 7) all of the hybrids in this panel contain no 
other human chromosomes apart from the region of chromosome 
21 indicated in Figure 8 (Van Keuren et al. 1986a). It can be 
stated with confidence, therefore, that any bands visible in 
the DNAs of the other hybrid cell lines of the panel are due 
to hybridisation with sequences on chromosome 21.
The filters shown here were washed at normal 
stringency and under these conditions it is apparent that 
both probes show almost identical multiple-band hybridisation 
patterns. This suggests that these two probes detect homology 
with the same set of sequences in the human genome. With 
regard to the regional localisation of these sequences on
chromosome 21 :
(i) there are fewer bands in lane 4 relative to lane 3.
Hybrid 153E7B-X (lane 3) is known to contain the human
chromosome 21 centromere, while 2Furl (lane 4) has only a 
small portion, if any, of a human centromere (Van Keuren 
et al. 1986a). This suggests that these probes map to the
pericentromeric region of chromosome 21, and the bands 
visible in lane 4 are due to hybridisation to this region of 
the chromosome.
(ii) The only other hybrid in this panel which is known to 
lack the centromere of human chromosome 21 is 8q- (lane 7).
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This hybrid contains the terminal part of chromosome 21 
(q22.3 - qter) as part of an 8;21 translocation and therefore 
contains the centromere of chromosome 8. The paucity of bands 
found in the DNA of this hybrid supports the localisation of 
sequences homologous to JG51/JG73 to the pericentromeric 
region of chromosome 21, and suggests that the few bands 
visible might be due to hybridisation with homologous 
sequences in the pericentromeric region of chromosome 8.
(iii) The hybridisation pattern with hybrid AlWBf2 (lane 8) 
is also of interest. The region of chromosome 21 present in 
this hybrid does not include the centromere. It might be 
expected, therefore, that only a small number of bands would 
be visible in the DNA of this hybrid. This is obviously not 
the case, however, and multiple homologous sequences are 
evident in lane 8 of the panel. This result confirms that 
there are other human chromosomes present in this hybrid, and 
that probes JG51 and JG73 detect homologous sequences on 
these chromosomes.
(iv) It is also interesting to note that there are some 
differences in the intensity of bands between lanes 1 and 2. 
Both of these hybrids (THYB133R and 72532X6) contain 
chromosome 21 as their sole human chromosome. The variations 
in band pattern between these two must therefore represent 
differences in the presence, distribution or organization of 
sequences homologous to these probes on the different 
chromosome 21s present in these hybrid cell lines.
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3.2.9 Summary of Characterisation of Probes Isolated 
from the Lawrence Livermore Sorted Library 
The isolation and characterisation of recombinant 
clones from this library can be summarised as follows :
Approximately 40 000 plaques screened
480 plaques picked
1
120 tested
I
23 had inserts
2 mild repeats13 single-copy8 repetitive
Details on regional localisation
presented in Table 3/Figure 15
Probe Department 
Name
HGM Regional
Designation Localisation
JG12 GMG21S8 D21S85 q22.1 - qter
JG21 GMG21S9 D21S86 q2.1 - q22.1
JG22 GMG21S10 D21S87 q22.1 - qter
JG24 GMG21S11 D21S88 q22.1 - qter
JG51 GMG21S12 D21S89 pericentromeric
JG62 GMG21S13 D21S90 q2.1 - q22.1
JG63 GMG21S14 D21S91 q22.1 - qter
JG72 GMG21S15 D21S92 q2.1 - q22.1
JG73 GMG21S16 pericentromeric
JG77 GMG21S17 D21S93 q22.1 - q22.2
JG81 GMG21S18 D21S94 q22.1 - qter
JG90 GMG21S19 D21S95 q2.1 - q22.1
JG99 GMG21S20 D21S97 q2.1 - q22.1
JG108 GMG21S21 D21S99 q22.1 - qter
JG373 GMG21S22 D21S101 q22. 3
Table 3 : Summary of Regional Localisation of Probes 
on Chromosome 21
Notes : 1. Probe JG73 has not yet been registered 
with the Yale Human Gene Mapping Library.
2. Although the regional localisation 
21q2.l-21q22.1 is given for 5 of the 15 
probes, there are slight differences in 
regional localisation for these probes, 
due to the use of different hybrid cell 
lines. For details see Figure 15.
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3.3 Screening of Recombinants for Restriction Fragment 
Length Polymorphisms (RFLPs)
DNA probes from chromosome 21 which detect RFLPs are 
potentially of great value in the determination of the origin 
of nondisjunction in Down's syndrome families. Many of the 
chromosome 21 probes isolated here were tested for RFLPs 
using a range of restriction enzymes and DNA samples from 
different individuals.
3.3.1 Screening for RFLPs using 5 DNA Samples
Originally, a set of DNA blots of samples from 5
different individuals was used and included digestions with
15 different restriction enzymes. As the results obtained
with polymorphic sequences close to the centromere are less
prone to interference caused by recombination (see
1.2.3
Introduction, Section 1.jkYt the emphasis was placed on 
screening probes from this region of the chromosome. The 
filters were therefore hybridised with DNA probes JG21, JG62, 
JG72, JG77, JG81, JG90, JG99 and JG108.
Two RFLPs were detected using this panel of filters : 
these were shown by probe JG77 with the enzyme Msp I and 
probe JG99 with the enzyme Pst I. Figure 16(a) shows the 
original autoradiograph illustrating the JG77/Msp I 
polymorphism, while Figure 16(b) demonstrates this RFLP on a 
further 12 individuals. The sizes of the polymorphic alleles 
were found to be 6kb and 3kb, respectively. There is also a 
constant band of 5.0kb, which appears in every genomic DNA
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sample. (Details on the sizing of bands given in Materials 
and Methods, Section 2.6.6). The JG99/Pst I polymorphism is 
demonstrated in Figure 17; the alleles in this case were 
found to be 7.0 and 6.6kb, respectively.
3.3.2 Screening for RFLPs using 7 DNA Samples
It was decided at this point that in order to increase 
the probability of detecting RFLPs, DNA from 7 different 
individuals should be digested with the same series of 
enzymes. This RFLP screening panel revealed only one 
additional polymorphism, however, as detected by probe JG90 
with the enzyme Nde II. This probe/enzyme combination gives 
allele sizes of 1.8 and 2.2kb, respectively, with a constant 
band at 1.2kb on genomic DNA samples (autoradiographs for 
this RFLP not shown).
Constant 8and— ►
F o i lowm
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ie  <14-
2 3 4 - 5
Consfarrt 8gn4 
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-yAllcle I (M)
-All€lc2(3kb)
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I 2 3  4- 5 6 1 8 9 io ii 12.
■/Allele
-/Allele 2
(b)
Figure 16 : Autoradiographs demonstrating the JG77/Msp I 
polymorphism on (a) five and (b) twelve 
unrelated individuals.
iAllele 2
Allele I ("7kb') 
Allele Z (6.6kb)
1 2  3 4-
(a)
Following
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I 2 3 4 5 6 T S 10 II 12.
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(b)
Figure 17 : Autoradiographs demonstrating the JG99/Pst I 
polymorphism on (a) four and (b) twelve 
unrelated individuals.
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3.3.3 Screening for RFLPs using Longer Gels
The possibility was considered that some RFLPs could 
perhaps remain undetected due to the fact that the size 
difference between the polymorphic alleles was insufficient 
to allow their resolution on the normal (10cm long) gels, in 
the hybridisation pattern shown by probe JG81 with the 
restriction enzyme Pvu II (Figure 18a), for example, there is 
a slight variation in the distance migrated by the upper band 
on the filter. This could be an electrophoresis artefact, but
it was also considered possible that this might be a "poorly
resolved" RFLP. To test this, DNA samples were run on 20cm 
long gels. A set of 12 genomic DNAs and a total of 20
restriction enzymes were screened in this way.
Use of longer gels for RFLP screening of probe JG81 
demonstrates quite clearly that this probe does detect a 
polymorphism with the enzyme Pvu II (Figure 18b), confirming 
the above theory. The sizes of the polymorphic alleles are
8.5 and 8.0kb, respectively, with a constant band at 3.5kb. 
The fact that there is only a small difference in size 
between the alleles explains the initial difficulty in 
resolving this polymorphism on the shorter gels.
The restriction enzyme Eco RV was introduced into the 
RFLP screening panel at this stage, and its inclusion allowed 
the detection of another RFLP with probe JG81, as shown in 
Figure 18c. There is a constant band at 7.5kb, and 
polymorphic alleles at 5.0 and 4.5kb, respectively.
JMt
m  M  m•*  •»
Allele I («• Ski) 
Allele2 (Ski)
m
Figure 18 : Autoradiographs demonstrating the JG81/Pvu II 
polymorphism on (a) 10cm and (b) 20cm long 
gels; (c) demonstrates the JG81/Eco RV
polymorphism on long (20cm) gel.
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3.3.4 Summary of RFLP Screening
Table 4 gives statistical data on the 5 RFLPs detected 
during this project. The JG77/Msp I polymorphism was used to 
analyse Down's syndrome families to determine the origin of 
the extra chromosome, as described in section 3.4. This 
explains the greater number of individuals tested with this 
RFLP. Also shown in Table 4 is the polymorphism information 
content (PIC) for each probe/enzyme combination. This is a 
measure of the "usefulness" of a particular polymorphic DNA 
locus, and in the present context estimates the likelihood of 
it being informative in the analysis of Down's syndrome 
families. (The formula for derivation of the PIC is presented 
in Skolnick & White, 1982).
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3.3.5 Hybridisation of Mild Repeat Probes to the Long 
RFLP Screening Panel
There were two reasons for hybridising probes JG51 
and JG73 to this panel: (i) to screen for RFLPs in the same 
manner as for the single-copy probes, and (ii) since it 
appears that these probes display very similar patterns of 
hybridisation to human genomic and to somatic cell hybrid 
DNAs digested with the enzyme Hind III (Figure R14), this was 
also an attempt to determine whether other restriction 
enzymes showed up any differences in the chromosomal 
organisation of these probes.
This latter question is easily answered - for all 20 
enzymes tested, both probes gave identical band patterns. 
Examples are shown in Figure 19 for the enzymes Pvu II and 
Hae III. This suggests that these two probes share extensive 
sequence homology.
Following Page
JG51/PVU II JG73/Pvu II
I 2  3  4 - 5 6 1  H  l o  II i l  l 2  3  4  5  6  7  M  10 ||  12.
JG73/Hae IIIJG51/Hae III
Figure 19 : Hybridisation patterns of probes JG51 and 
JG73 to human genomic DNA samples digested 
with restriction enzymes Pvu II and Hae III.
(Arrows adjacent to Pvu II photographs 
indicate possible RFLP - see section 3.3.5)
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The question of whether or not these two probes 
detect RFLPs is more difficult. It is certainly the case that 
some restriction enzymes produce variations in band pattern 
between different individuals. For example, in Figure 19(a), 
which shows hybridisation to DNA samples digested with the 
enzyme Pvu II, lanes 1, 7 and 12 are lacking a band at the 
point indicated on the film. If this is an RFLP, then it is 
impossible to determine the position of the other allele(s) 
on the filter. Another possibility perhaps is that the 
individuals represented in these three tracks are deleted for 
the particular region of DNA represented by this band.
Hybridisation to DNA samples digested with the enzyme 
Xmn I (Figure 20a - results shown for JG73 only) reveals a 
very interesting band pattern. At approximately 8/9kb, there 
appears to be a simple, two-allele RFLP, with some 
individuals homozygous for the upper band (lanes 6,7,8,9 and 
12), some heterozygous (lanes 1,3,4,5 and 11) and one person 
homozygous for the lower band (lane 2). However, if one 
considers that lanes 1 to 5 and lane 11 contain DNA from 
normal males, while the other lanes contain female DNA, 
another explanation for the observed pattern of bands is 
possible. It might be the case that the lower of the two 
bands is male-specific, representing hybridisation to the Y 
chromosome, while the upper band is merely deleted in the DNA 
of the individual in lane 2, in a similar way as described 
above for the enzyme Pvu II.
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Support for this is provided by examination of the 
band patterns obtained with these probes and the enzymes 
Hind III, Eco RI and Eco RV (Also shown in Figure 20). In 
each case a strong signal indicating hybridisation to a 
fragment of about 8kb is visible in the lanes of the filter 
containing DNA from males; this band does not appear in DNA 
samples from the females used here. It is interesting to note 
that for all four probe/enzyme combinations shown in Figure 
20, the putative Y-band is the same size. Further experiments 
are necessary to clarify this situation, and there was 
unfortunately insufficient time for these to be carried out.
In conclusion, it is unlikely that any variations in 
DNA sequence between individuals detected using these mild 
repeat probes could be used to follow the inheritance of 
chromosome 21 within families until the particular fragments 
involved were assigned exclusively to that chromosome.
following S0)
ECO RI
Figure 20 : Hybridisation patterns of probe JG73 on genomic 
DNA samples digested with restriction enzymes 
Xmn I, Hind III, Eco RI and Eco RV. Fragment 
sizes (in kb) are indicated to the left of the 
photographs.
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3.4 Analysis of Nondisjunction in Down's Syndrome Families 
using RFLP Markers and Cytogenetic Heteromorphisms 
As mentioned previously, chromosome 21-specific DNA 
probes which detect RFLPs are potentially of great value in 
determination of the parental origin of nondisjunction in 
Down's syndrome families. If one considers a Down's syndrome 
nuclear family consisting of father (F), child (C) and mother 
(M) (these abbreviations are used in Figures 21 to 30, 
inclusive), and the analysis of such a family with a simple 
two-allele polymorphic probe, then there are essentially only 
eight possible band patterns which will reveal the origin of 
the extra chromosome. These are illustrated in Figure 21.
In the first type of informative pattern (Figure 21a to 
d), both parents are homozygous for different alleles. The 
child has two copies of one allele, and one copy of the 
other. For example, if the band pattern was found to be that 
shown in Figure 21b, then it is obvious that because the 
child has two copies of the lower allele, which the father 
does not have, the extra chromosome must have come from the 
mother. Given only this information it is impossible to tell 
at which meiotic division nondisjunction occurred.
In the second type of band pattern (Figure 21e to h), 
one parent is heterozygous and the other is homozygous. The 
child has two copies of the allele not present in the 
homozygous parent, and one copy- of the other allele. 
Considering the pattern shown in Figure 21e, and following 
the same reasoning as used above for Figure 21b it is
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possible to say that the extra chromosome is derived from the 
mother. In this example it is also possible to tell that 
since the mother has two different chromosome 21s in relation 
to this marker, the only way in which she could pass on two 
identical copies of the chromosome would be if nondisjunction 
took place at the second meiotic division. Nondisjunction in 
this case can be localised to the second maternal meiotic 
division. It should be noted, however, that recombination 
between the centromere and DNA markers on the long arm of the 
chromosome can lead to misinterpretation of RFLP results in 
which nondisjunction is localised to a specific meiotic 
division. An example of this is presented in section 3.4.5 
for family 25-26-27 and a consideration of this problem is 
presented in section^ of the discussion.
A total of 33 Down's syndrome nuclear families 
consisting of father, mother and affected child (or fetus in 
some cases) were tested using five probe/enzyme systems to 
determine the origin of nondisjunction. To ensure 
confidentiality, each family was allocated a number. In 
addition to the JG77/Msp I polymorphism, four polymorphic 
probes supplied by other workers were used. (See Table 5, 
which also shows the number of families tested and the number 
informative for each marker. Five of the Down's syndrome
families were also analysed using Q-banding heteromorphisms
and in three cases the origin of nondisjunction was 
determined. Details are given below, along with the RFLP 
results for each of the informative families.
(* - Cytogenetic studies'performed by Dr. Elizabeth Boyd)
F C M F C M
—  — —  --  —
--- ■ —
—  ~
(a) (e)
F C M F C M
------  --- —
------ —  ~
(b) (f)
F C M F C M
_  —— mam
—  --- -  ~
(c) (g)
F C M F C m
---  — i i
—  — —  _  —
(d) (h)
Figure 21 : Diagram showing possible informative band 
patterns for a two-allele RFLP in Down's 
syndrome nuclear families.
(F - Father, C - Child, M - Mother)
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3.4.1 Family 1-2-3 (Figure 22)
Examination of the band pattern with the 10.2/Hind III
RFLP shows that the father and mother are homozygous for the
9.5 and 8.5kb alleles, respectively. The child has two copies
of the 8.5kb allele and one copy of the 9.5kb allele. Since
neither of the father's chromosome 21s has the 8.5kb allele,
the extra chromosome in this case must therefore be derived
from the mother. The band pattern with the D2lK9/Taq I marker
localises the nondisjunctional event to the second maternal
meiotic division, since this is apparently the only way in
which the mother can donate two identical chromosome 21s to
her offspring, ~ Reconrtbirwhovi, u^ lik-ely^  /uay jrbll
Wave, occorred,).
3.4.2 Family 4-5-6 (Figure 23)
The patterns for the 10.2/Hind ITI and E8/Msp I RFLPs 
shown here are essentially identical to those shown in Figure 
22 for probes 10.2 and D21K9 with family 1-2-3. The 
interpretation of the results is therefore the same, and 
demonstrate maternal nondisjunction at the second maternal 
meiotic division.
(* - Results in which the meiotic stage of nondisjunction is
defined by probes E8, H8, JG77 and 10.2 are subject to the 
effects of recombination and cannot be considered definite at 
this stage).
AMele i (A-5kb) 
Allele 2 (3.5kb)
10.2/Hind III
Allele I Okb) 
Allele2 fekb)
D2lK9/Taq I
Figure 22 : RFLP results for family 1-2-3
Note : In this and subsequent figures, only the
polymorphic bands for the P21K9/Tag I
RFLP are shown. The sizes of the
constant bands are given in Table 5.
r o l L w m a  
Poge 101
f  c m
A lle le  I 0 .5 kb ) 
Allele 2 (S.5kbK/~"*’
10.2/Hind in
Allele I (4.| kb) 
Allele 2 (3.4kb)
E8/Msp I
Figure 23 : RFLP results for family 4-5-6
Note : in this and subsequent figures, the 
0.7kb band for the E8/Msp I RFLP is not 
shown, as its presence or absence from the 
filter can be inferred indirectly from the 
3.4kb band.
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3.4.3 • Families 7-8-9 and 13-14-15 (Figure 24)
The origin of the extra chromosome in both of these 
families was determined using the H8/Bgl II RFLP. The band 
patterns for both families are similiar to those discussed 
previously (Figure 21a and c, respectively), and it is 
possible to determine that the extra chromosome 21 was of 
paternal origin in family 7-8-9 and of maternal origin in 
family 13-14-15. These band patterns do not provide any 
information about the meiotic division at which 
nondisjunction occurred.
3.4.4 Family 16-17-18 (Figure 25)
Two autoradiographs are shown for this family with 
the P21K9/Taq I RFLP because in one of these (a) it is very 
difficult to determine which allele is present in duplicate 
in the DNA of the child. In the other film (b), although the 
bands are less distinct, it is clear that the child has two 
copies of the 7.0kb band, which shows that the additional 
chromosome was derived from the mother. This was confirmed by 
Q-banding studies, which also localised the n o n d is junctional 
event to the first maternal meiotic division.
F o I(c w M q
103
A lle le  I (I8.5kb)- 
AHele2 ( I2 3kb)'
F C  M
Allele I 
A l le le  Z
F  C M
15 U  • 15
Figure 24 : RFLP results for families 7-8-9 and 
13-14-15 with the H8/Bgl II RFLP.
Allele I 0W>\ 
Al(ele2 (fefcb).
F CM
Fol lo w in g  
PQge 103
/A lle le
A l l e l e  1
Figure 25 : RFLP results for family 16-17-18 with 
the D2IK9/Tag I RFLP.
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3.4.5 Family 25-26-27 (Figure 26)
Examination of the band pattern obtained using the 
H8/Bgl II RFLP with this family shows that the additional 
chromosome 21 is of maternal origin. The results obtained 
using JG77/Msp I confirm maternal origin of nondisjunction 
and show this to have occurred at the second meiotic 
division. The hybridisation pattern obtained with the 
D2lK9/Tag I marker provides no information regarding the 
parental origin of the extra chromosome; given the prior 
knowledge that maternal nondisjunction has occurred in this 
family, however, the band pattern, with this RFLP marker 
demonstrates that nondisjunction took place at the first 
maternal meiotic division. Q-banding studies were informative 
in this family and these also showed nondisjunction to have 
taken place at the first maternal meiotic division.
The contradiction between the JG77 and D2lK9/Q-banding 
results demonstrates that recombination has occurred between 
these two markers prior to nondisjunction at the first 
maternal meiotic division.
3.4.6 Family 28-29-30 (Figure 27)
The origin of the additional chromosome 21 in this 
family was found to be maternal by examination of the results 
with E8/Msp I. Studies of the cytogenetic heteromorphisms 
confirmed this and showed that the nondisjunctional event 
occurred during the first meiotic division in the mother.
A lk ie  I (iS-Skb) —► »  •
A lle le  2 ( i2-3 lcl?)— *• •
H8/Bgl II
A l l e l e  I ( fckb)
Conj+qot Ban4 
(5kb)
AHele 2 (3kk)—► •
JG77/MSP I
F e n
A l l e l e  I ( i k b U  ,
A lle le  2 Ukb)
D21K9/Taq I
Figure 26 : RFLP results for family 25-26-27
A l le l e 2 (3.4tb)—►
Figure 27 : RFLP results for family 28-29-30 with 
the E8/Msp I polymorphism
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3.4.7 Family 31-32-33 (Figure 28)
Results for this family are presented for JG77/Msp I, 
10.2/Hind III and D2lK9/Taq I. The polymorphic alleles for 
the first two are identical, and show that the extra 
chromosome is of paternal origin. Taking this into account, 
it is possible from consideration of the band pattern found 
with D21K9/Taq I to state that since none of the child's 
chromosome 21s have the 6.0kb allele nondisjunction must have 
occurred during the second paternal meiotic division.
3.4.8. Family 37-38-39 (Figure 29)
Results obtained in this family with JG77/Msp I, 
10.2/Hind III and H8/Bgl II are shown. Interpretation of the 
pattern with the first probe/enzyme system is straightforward 
and shows that the extra chromosome was derived from the 
mother. The band pattern obtained with probe 10.2/Hind III in 
this family is very interesting. It appears that one of the 
chromosomes in the father has the 9.5kb allele, but his other 
chromosome shows a band which lies somewhere between 9.5 and 
8.5kb. This is probably the result of a DNA rearrangement in 
one of the father's chromosome 21s, leading to a larger or 
smaller fragment of DNA becoming homologous to the probe 
used. This does not affect the interpretation of the band 
pattern with respect to determination of the origin of 
nondisjunction, however, since it is evident that the father
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has not passed on the chromosome carrying the unusual 
fragment. The father has transmitted his "normal" 9.5kb 
allele to the child, while the mother has obviously donated 
two copies of the 8.5kb allele. This confirms the maternal 
origin of the extra chromosome defined by JG77/Msp I above.
Given the knowledge that the extra chromosome was 
derived from the mother, the band pattern obtained with 
H8/Bgl II shows that the nondisjunctional error occurred at 
the first maternal meiotic division.
3.4.9 Families 90-92, 135-137 and 153-155 (Figure 30)
Each of these families proved to be informative for 
the 10.2/Hind III polymorphism. The results are explained as 
follows : In the first family (90-91-92) the child has two
copies of the upper (9.5kb) allele and one copy of the lower 
(8.5kb) allele. The 9.5kb allele is not present on either of 
the mother's chromosome 21s, and so the extra copy of 
chromosome 21 must be of paternal origin. These results also 
indicate that nondisjunction occurred during the second 
meiotic division, since this seems to be the only way in 
which the child could receive two copies of the 9.5kb allele 
from the father. Following similar reasoning, the band 
pattern in family 135-136-137 demonstrates that 
nondisjunction must have occurred during the second maternal 
meiotic division. The results for the third family 
(153-154-155) are identical to others presented above and 
show only that the extra chromosome was maternal in origin.
Allele I (6kb) 
Con5+an+ Band (5kb)
A lle le  Z Okb)
JG77/Msp I
Allele I (5-5kb) 
A lle le  2 (8 .5 kb)
A l l e l e  I ( 7 kb) 
A l l e l e  2  (6 kb)
F C m
***** WW& * *
•
'l
10.2/Hind III
F c M
($ rnmm_
D2lK9/Taq I
Figure 28 : RFLP results for family 31-32-33
A l l e l e  I (€>kb) 
C o n B q n 4  (5kb).
Allele 2 (3kb).
«
JG77/Msp I
Allele. I (4.5-kb)
r
Allele 2 (8.5kb)
F c M
10.2/Hind III
A l l e l e  I ( ig .Skb) 
A l l e l e  2 ( 12.3 kb)'
H8/Bgl II
Figure 29 : RFLP results for family 37-38-39
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Figure 30 : RFLP results for families 90-91-92, 
135-136-137 and 153-154-155 with 
the 10.2/Hind III RFLP.
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3.4.10 Summary of Nondisjunction Analysis of Down's
Syndrome Families
Table 6 lists the families in which the origin of the 
extra chromosome could be determined and summarises the 
cytogenetic and RFLP results for these families, in the three 
cases where Q-banding results allowed the parental origin of 
the additional chromosome 21 to be determined, these results 
were in agreement with the RFLP analyses. Table 7 presents 
data on the parental ages in each of the informative 
families. Given the small sample size, and the lack of an 
appropriate control population, however, it was considered 
unwise to draw any conclusions regarding the relationship 
between parental age and nondisjunction based on these 
results.
It can be seen from Table 6 that the additional 
chromosome 21 was shown to be of maternal origin in 9 of the 
12 cases (75%), and of paternal origin in 3 (25%). The 
meiotic stage of nondisjunction is also shown in Table 6, but 
the effects of recombination on the definition of the meiotic 
stage of nondisjunction by polymorphic DNA markers should be 
noted at this point. For example, it may be the case that in 
those families apparently showing nondisjunction at the 
second meiotic division, the event might have actually taken 
place at the first meiotic division, following recombination 
between the centromere and the polymorphic marker in 
question, as described for family 25-26-27.
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In five families, however, the meiotic stage of 
nondisjunction is defined either by cytogenetic analysis of 
Q-banding heteromorphisms, or by the pericentromeric RFLP 
marker D21S13/Tag I, or both, and can therefore be localised 
with confidence to a particular meiotic division. Of these, 
three families (16-17-18, 25-26-27 and 28-29-30) show
nondisjunction at the first maternal meiotic division, while 
the other two show nondisjunction at the second maternal 
(Family 1-2-3) and second paternal (Family 31-32-33) meiotic 
divisions, respectively. The ratio of nondisjunction 
occurring at each meiotic division in these families is as 
follows :
Maternal I Maternal II Paternal I Paternal II 
0 . 6 0 . 2 0 0.2
All other results presented in Table 6 concerning 
7 localisation of nondisjunction to a specific meiotic division 
must be considered as provisional until they can be confirmed 
or corrected using pericentromeric markers.
Follow ^  
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Family Cytogenet ic Locus: D21S13 D21S93 D21S25 D21S17 D21S15 Meiotic division
Analysis Probe: D21K9 JG77 10.2 H8 E8 at which
Enzyme: Taq I Msp I Hind III Bgl II Msp I nondisjunction
Locat ion: qll.l (q22.1 - q22.2) q22. 3 q22.3 occurred
F 1 _ 11 11 11 12 _
C 2 - 122* 112 122* 111 - Maternal II
M 3 - 12 12 22 11
F 4 ab 12 12 11 11 11
C 5 aaa 112 122 122* 111 122* Maternal II
M 6 aa 12 12 22 11 12
F 7 _ 22 12 22 11 12
C 8 - 222 122 222 122* 122 Paternal
M 9 - 12 12 22 22 12
F 13 ab _ 11 22 22 12
C 14 aab - 112 222 112* 112 Maternal
M 15 ac - 12 22 11 11
F 16 ab 22 11 _ 12 _
C 17 bed* 112* 111 - 112 - Maternal I
M 18 cd 11 11 - 12 -
F 25 ab 11 11 _ 11 _
C 26 acd* 112§ 122* - 122* - Maternal I
M 27 cd 12 12 - 22 -
F 28 ab 12 12 _ 12 22
C 29 bed* 112 112 - 122 112* Maternal I
M 30 cd 11 11 - 12 11
F 31 _ 12 22 22 12 _
C 32 - 111§ 122* 122* 122 - Paternal II
M 33 - 11 11 11 12 -
F 37 _ _ 11 13 11 _
C 38 - - 122* 122* 112§ - Maternal I
M 39 - - 22 22 12 -
F 90 _ _ _ 12 - _
C 91 - - - 112* - - Paternal II
M 92 - - ' - 22 - -
F 135 _ _ _ 22 _ _
Or 136 - - - 112* - - Maternal II
M 137 - - - 12 - -
F 153 _ _ - 22 - -
C 154 - - - 112* - - Maternal
M 155 - - - 11 - -
Table 6 : Summary of Cytogenetic and RFLP Analysis of Down's syndrome Families
Notes: 1. F - Father, C - Child, M - Mother
2. Cytogenetic markers are arbitrarily assigned as a, b, c or d
3. Different alleles for RFLP markers are denoted by 1 and 2, respectively,
except in the case of Family 37-38-39 with the 10.2/Hind III marker, where 
the father's rare allele is labelled "3"
4. The map position 21q22.1 - q22.2 is given for both JG77 and 10.2;
the relative order of these probes on the chromosome is not known
5. * indicates results in which parental origin can be determined
6. § indicates results in which meiotic stage of nondisjunction can be inferred
Meiotic Stage of Number Mean Maternal Age Mean Paternal Age
Nondisjunction of Cases_______________________________________
Maternal I 4 32.5 34.5
Maternal II 3 39 40
Maternal I or II 2 35.5 37.5
All Maternal 
Nondisjunctions
9 35 37
Paternal I 0 — _
Paternal II 2 35.5 34
Paternal I or II 1 27 29
All Paternal 
Nondisjunctions
3 32 33
Table 7 (b) - Parental age data on Down's syndrome families
rollowmc 
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Family Father1s 
Age
Mother1s 
Age
Origin of 
Nondisjunction
1-2-3 41 42 Maternal II
4-5-6 42 37 Maternal II
7-8-9 29 27 Paternal
13-14-15 32 30 Maternal
16-17-18 43 33 Maternal I
25-26-27 31 34 Maternal I
28-29-30 34 30 Maternal I
31-32-33 27 26 Paternal II
37-38-39 30 33 Maternal I
90-91-92 44 42 Paternal II
135-136-137 37 37 Maternal II
153-154-155 43 41 Maternal
Mean : 34 36
Table 7cl: Parental age data on Down's syndrome families
(Ages given are at birth of affected child or at 
termination of fetus diagnosed as having Down's 
syndrome)
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3.5 Testing of Chromosome 21 DNA Probes for Expression
using Northern Blots
RNA samples were prepared from age- and sex-matched 
normal and Down's syndrome fetal brain tissues and used to 
prepare Northern blot filters. These were hybridised with 
probes JG72, JG77, JG90, JG99 and JG108.
The actin gene probe pAM91 (Minty et al. 1982) was used 
as a control probe for these filters to ensure that the same 
amount of RNA was added to each lane, but pAM91 in fact 
showed a 3:2 dosage ratio of hybridisation signal between 
Down's syndrome and normal RNA (results not shown). This 
probe was subsequently hybridised to chromosome 21 mapping 
panel 6, and a signal was evident in the lane containing DNA 
from the 21-only hybrid, THYB133R (results not shown), 
indicating the presence of sequences homologous to this probe 
on chromosome 21 and explaining the observed increase in 
dosage of hybridisation.
Regarding the testing of the chromosome 21-specific 
sequences : probe JG99 did not hybridise to either RNA 
sample, suggesting that this clone is not part of an 
expressed sequence. Figure 33 shows the hybridisation 
patterns of the other four probes on the Northern blot 
filters. Probes JG72 and JG108 seem to be expressed at a 
significant level only in Down's syndrome brain. JG77 and 
JG90 are expressed in both normal and trisomy 21 brain 
tissue, and at a much higher level in the latter.
Densitometry analysis (results not shown) of the
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autoradiographs for these two probes showed a five-fold 
increase in signal intensity between normal and Down's 
syndrome brain samples.
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CHAPTER FOUR
DISCUSSION
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The discussion is divided into 5 main sections :
Section 4.1 presents an evaluation of the different 
recombinant libraries and screening methods used in the 
current project.
Section 4.2 discusses the regional mapping of recombinants 
isolated during the present study and considers the 
usefulness of somatic cell hybrids for this purpose.
Section 4.3 is concerned with the screening of recombinant 
probes for the ablity to detect restriction fragment length 
polymorphisms (RFLPs), and evaluates the effectiveness of 
different RFLP screening strategies.
Section 4.4 discusses the results obtained using chromosome 
21-linked RFLP and cytogenetic markers to study 
nondisjunction in Down's syndrome families.
Section 4.5 presents a brief summary of recent developments 
in mapping of genes to chromosome 21, in particular those 
involved in Alzheimer's disease, and considers the possible 
relevance of DNA sequences isolated during the present study 
to the pathogenesis of Down's syndrome and Alzheimer's 
disease.
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4. 1____ Isolation of Recombinant Clones from Sorted
Chromosome Libraries - Evaluation of the 
Different Screening Methods Used
4.1.1 Preassociation/cDNA screening method
The first method, used with the sorted chromosome 21 
library of Young et al. (1983), involved the prehybridisation 
of plate filters with non-radioactive human genomic DNA, 
followed by hybridisation with labelled cDNA prepared from 
Down's syndrome fetal liver mRNA. It was hoped that this 
technique would select for single- or low-copy number, 
expressed DNA sequences, as these are more likely to
represent parts of genes. All six of the clones isolated
(J21.1, J21.2, J21.3, J21.4, J21.5, J21.6) contained highly
repeated DNA, however, demonstrating the failure of this 
method to pick out low copy number sequences.
It was considered likely that due to the large insert 
sizes found in these six clones (which range from 9.5kb to 
' 13.5kb), they might contain interspersed single-copy and
repetitive human DNA sequences. This possibility was tested 
using the pre-reassociation technique (Sealy et al. 1985) and 
two of the clones, J21.1 and J21.2, were shown to hybridise 
with non-repetitive DNA sequences. Regarding clone J21.1, an 
attempt was made to separate this part of the cloned DNA from 
the repetitive DNA also present, but this proved inpossible.
The single-copy human DNA sequence in clone J21.2 was 
found to hybridise with sequences on other human chromosomes,
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but not to chromosome 21. This is not surprising, given that 
in the library used only 60% of the human DNA inserts are 
derived from chromosome 21, while the remaining 40% map to 
chromosome 22 (B.Young, personal communication).
Due to the lack of success with clones J21.1 and J21.2, 
the four remaining clones were not tested for the presence of 
single-copy human DNA sequences and because of the repetitive 
nature of all six'inserts, none were tested for expression. 
As such it was not possible to evaluate the degree of success 
of this method in isolating expressed sequences.
The cDNA screening technique described in this project 
was used successfully with a similar recombinant library and 
allowed the isolation of five single-copy DNA sequences from 
the human Y chromosome (Florentin 1987). For all five of 
these probes, however, this involved subcloning of the 
single-copy sequence from a larger original clone which also 
contained repetitive DNA sequences, as attempted here for 
clone J21.1. This is however a difficult and time-consuming 
process.
4.1.2 Selection of plaques which failed to hybridise 
with labelled human genomic DNA
A chromosome 21-specific flow-sorted recombinant DNA 
library supplied by the National Gene Library Project 
(Lawrence Livermore laboratory) was also screened during the 
current project. This library was prepared by digestion of 
flow-sorted chromosome 21 DNA with the restriction enzyme
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Hind III and subsequent cloning into the Hind III site of 
the bacteriophage vector Charon 21A.
This library has two main advantages over that 
described above (Young et al. 1983) : firstly, it is
estimated to contain over 95% chromosome 21 inserts 
(Information supplied with library), increasing the 
likelihood of isolating DNA sequences from chromosome 21. 
Secondly, the vector used will only accept for cloning 
fragments of less than 9.1kb (Fuscoe et al. 1987) this 
relative reduction in the size of human DNA inserts increases 
the probability of isolating clones containing only 
single-copy DNA sequences.
The method used for the selection of recombinants from 
this library involved the isolation of plaques failing to 
show hybridisation with radioactively labelled human genomic 
DNA, in the hope that these would contain human DNA inserts 
of low copy-number. This method had been used previously with 
the sorted chromosome 21 library mentioned above (Young et 
' al. 1983) to isolate five chromosome 21-specific DNA probes 
(Stewart 1984, Stewart et al. 1985, Davies et al. 1984). 
Three of these five recombinants have subsequently been used 
to isolate homologous clones from a cDNA recombinant library 
(Neve et al. 1986), which shows that they represent expressed 
sequences. This demonstrates that it is possible to pick out 
single-copy, expressed sequences from this library and 
suggests a possible flaw in the cDNA method described for the 
selection of such recombinants.
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An obvious problem with the selection of plaques 
failing to hybridise with human genomic DNA is that a 
significant proportion of plaques picked will not contain any 
human DNA. This was found to be the case here, with 80% of 
the plaques examined falling into this category. Of the 24 
clones with human DNA inserts isolated, however, two-thirds 
contained single or low copy-number human DNA sequences, 
demonstrating the usefulness of this technique.
The main advantage of this method over the previous one 
is that it allows rapid isolation and characterisation of 
recombinant clones : following the initial selection of
non-hybridising plaques, it is a relatively simple matter to 
purify the bacteriophage DNA and digest with a restriction 
enzyme to test for the presence of human insert DNA. The 
current practice of radioactively labelling DNA sarrples 
excised from LMP agarose directly allows inserts to be tested 
immediately to establish whether they contain single-copy 
sequences. As described in the text, these can then be used
in Southern blot experiments, allowing them to be regionally
mapped on the chromosome and tested for the presence of
RFLPs, and on Northern blots to determine whether they
represent expressed sequences.
Although it is not possible to compare the two 
screening strategies directly, as they were not used to 
screen the same recombinant library, the main objectives of 
isolating (i) single-copy and (ii) expressed sequences were 
more easily accomplished using the second technique described
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(i.e. selection of plaques failing to hybridise with human 
genomic DNA), and as this method was the more practical and 
successful of the two it is recommended for this type of 
work.
Another method potentially of great value in the 
screening of such recombinant libraries is the use of an 
oligonucleotide probe complementary to the insertion site of 
the vector, as descibed by Fuscoe et al. (1987). This probe 
hybridises strongly to non-recombinants, but less stably when 
a cloned insert is present, and could be used in the 
selection of recombinant clones.
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4.2 Regional Mapping of DNA Sequences
on Chromosome 21
4.2.1 Consideration of the Usefulness of Somatic 
Cell Hybrids
Advances in the development of methods for the 
construction and characterisation of somatic cell hybrids 
have been one of the major contributing factors in the recent 
rapid evolution of the molecular genetic map of 
chromosome 21. Use of hybrids containing translocation 
derivatives of chromosome 21 in mapping experiments, as 
performed in the current study, has led to the accurate 
regional assignment of numerous DNA sequences (Van Keuren 
et al. 1986a, Korenberg 1987).
The utility of such chromosome 21 hybrid panels is 
limited, however, by the different translocation chromosomes 
available for study. This dependance on naturally occurring 
rearrangements limits the variety of hybrids that will be 
found and excludes many potentially informative chromosomal 
' rearrangements. In addition, the presence of non-chromosome 
21 human material in many of these hybrids confounds certain 
types of analyses, especially those involving repetitive 
sequences.
These problems have been overcome by some workers who 
have constructed somatic cell hybrids containing artificially 
fragmented pieces of chromosome 21 (Graw et al., 1985,
Graw et al., 1988). The method used involves X-ray 
irradiation of whole cells to fragment the genome.
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The segment of interest is then rescued by fusion of the 
irradiated cells to rodent cells and application of selective 
pressure. The authors have used this technique with some 
success in constructing a panel of Chinese hamster/human 
hybrids that contain segments of chromosome 21 centered about 
phosphoribosyl glycinamide synthetase (GARS), the selected 
marker.
Another possible problem associated with somatic cell 
hybrids is the occurrence of rearrangements between human and 
rodent chromosomes. These seem to occur frequently in 
interspecific somatic cell hybrids and the use of the 
differential G-ll stain to identify such recombinant 
chromosomes is advisable. Detailed molecular and cytogenetic 
characterisation of hybrids should also be carried out, due 
to the effects of deletion and other rearrangements. The 
hybrid cell lines used in the current project have been 
extensively characterised using both cytogenetic (including 
G-ll staining) and molecular methods (see Materials &
- Methods, Section 2.2). This allows the regional localisation 
of the probes presented here to be stated with a high degree 
of confidence.
4.2.2 Chromosomal Localisation of Probes Isolated
During the Present Study
All 15 probes isolated during this study have been 
regionally mapped on chromosome 21 using a range of somatic 
cell hybrids containing different parts of the chromosome.
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None of the sequences isolated from the recombinant library 
used here were derived from any other human chromosome. The 
contamination of such libraries with DNA sequences from 
chromosomes other than the desired one has been a problem in 
the past, but the development of bivariate flow-sorting of
human chromosomes (Deaven et al. 1986) has almost eliminated 
this problem.
Five of the probes were mapped more accurately using 
additional hybrid cell lines which contained different parts 
of chromosome 21. Obviously, the greater number of hybrids 
containing different parts of chromosome 21 used, the more 
accurately probes can be mapped.
Another useful technique in the chromosomal assignment 
of human DNA sequences is that of in situ hybridisation, 
although regional localisation on a small chromosome like 
chromosome 21 is quite difficult. It was intended that this 
method should be used with the mild repeat probes JG51 and 
JG73, since it is likely that this would demonstrate clearly 
whether or not these probes detected homology with sequences 
on human chromosomes other than chromosome 21. Unfortunately 
time did not allow these experiments to be carried out.
As shown in Figure 15, all of the probes isolated here 
map on the long arm of chromosome 21, half above and half 
below the q2.1/q22.1 junction defined by hybrid ACEM2-90.
None of the single-copy probes isolated here mapped to the 
short arm of chromosome 21. This is not surprising, because, 
to date, no single-copy or repeated probes specific to the
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short arm of chromosome 21, or any other acrocentric 
chromosome, have been isolated (HGM 9, 1988). It is likely 
that the difficulty in isolating such sequences arises from 
the occurrence of somatic recombination between rDNA 
sequences on non-homologous chromosomes (see, for example, 
Worton et al. 1987).
Probes JG51 and JG73 are of interest because of their 
multiple-band hybridisation patterns. It would appear that 
although originally isolated from a chromosome 21-specific 
recombinant library, these probes are closely related members 
of a mildy repetitive DNA sequence family, members of which 
are found on a number of human chromosomes including 
chromosome 21. The results obtained by hybridising these two 
probes to hybrid mapping panel 8 (Results Section 3.2.8, 
Figure 14) showed that a significant proportion of sequences 
homologous to these probes are present in the pericentromeric 
region of chromosome 21. This raises the possiblility that 
these sequences are members of the alphoid repeat family, 
'members of which are present in the centromeric regions of 
all human chromosomes (Willard 1985, Willard et al. 1986). 
Definite proof of this would require the demonstration of 
cross-homology with known alphoid sequences, or detailed 
molecular analysis of these sequences, and there was 
unfortunately insufficient time for these experiments to be 
carried out.
A mildly repetitive sequence which shows a very similar 
hybridisation pattern to probes JG51 and JG73 was isolated
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from a chromosome 21 recombinant library by virtue of its 
hybridisation to'a repetitve sequence originally derived from 
chromosome 12 (Law & Van Keuren 1986). The authors 
demonstrate that such cloned mild repeat sequences can be 
used in the molecular characterisation of rearrangements of 
human chromosome 21, using a similar technique to that 
described for the characterisation of a range of somatic cell 
hybrids containing different parts of chromosome 11 (Gusella 
et al. 1982). Given the similarities in hybridisation pattern 
between probes JG51/JG73 and that described by Law & Van 
Keuren, it is possible that JG51/JG73 could also prove useful 
in such analyses.
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4.3 Screening of Recombinants for Restriction Fragment
Length Polymorphisms (RFLPs)
The usefulness of arbitrary DNA sequences in human 
genetic analysis relies mainly on their ability to detect 
restriction fragment length polymorphisms (RFLPs), as 
described previously (Introduction, Section 1.2.3). The 
probability that an RFLP will be found depends upon (i) the 
number of individuals tested, (ii) the number of restriction 
enzymes used, and (iii) whether the probe being tested is 
X-linked or autosomal (see Hofker et al. 1986).
Two different strategies are generally applied in 
screening DNA probes for RFLPs. The first uses a few DNA 
samples and a large number of restriction enzymes, with the 
intention of revealing polymorphisms with high rare allele 
frequencies. The second method uses numerous DNA samples, but 
only a few restriction enzymes, and is intended to find as 
many RFLPs as possible, regardless of their frequency.
- 4.3.1 RFLP Screening with Few DNAs, Numerous Enzymes
Obviously, the fewer individuals examined, the more 
frequent a polymorphism must be in order to be detected. 
RFLPs detected in this way are therfore more likely to be
informative in the general population, since a greater number
of individuals will be heterozygous. A study in which DNA
probes from the X chromosome were screened, in this way 
confirms the usefulness of this method (Aldridge et al.
1984).
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In the present study, RFLP screening was initially 
carried out using DNA from 5 unrelated individuals digested 
with 15 different restriction enzymes. This revealed two 
RFLPs : JG77/Msp I and JG99/Pst I. Following further testing 
of these polymorphisms, the rare allele frequencies were 
found to be 0.33 and 0.16, respectively. It has been 
suggested that minor allele frequencies of less than 0.2 do 
not prove useful in the analysis of nondisjunction (Stewart 
et al., 1988). As such, only the JG77/Msp I polymorphism was 
used in the analysis of nondisjunction in Down's syndrome 
families. The origin of the additional chromosome was 
determined in 2 of the 14 families tested with this 
probe/enzyme combination, showing it to be of some value in 
this type of analysis.
4.3.2 RFLP Screening with Numerous DNAs, Few Enzymes
The second and most commonly used method to screen 
for RFLPs uses . a large number of DNA samples digested with 
few restriction enzymes. This increases the probability of 
detecting RFLPs, but means that a significant proportion of 
those found will have low rare allele frequencies (Skolnick & 
White 1982). Since only two RFLPs were detected in the 
present study using 5 DNA samples, further testing was 
carried out using 7 different DNAs. This revealed the 
JG90/Nde II polymorphism. This RFLP has a minor allele 
frequency of 0.3, suggesting that it should prove useful in 
nondisjunction analysis. It should be noted that Nde II was
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not used in the original, five-member screening panel, and it 
is likely that the relatively high frequency of this RFLP 
would have allowed its detection using only five DNA samples. 
Unfortunately, time did not allow the use of this RFLP in 
nondisjunction analysis.
4.3.3 RFLP Screening using Longer Gels
Another possible factor in RFLP screening, apparently 
neglected by many workers in the field, is that certain RFLPs 
may avoid detection because the difference in size between 
the polymorphic alleles is insufficient to allow their 
resolution on the agarose gels normally used in Southern blot 
experiments, which typically range from about 7cm to 12cm in 
length. This was confirmed in the current project, where a 
slight variation in the band pattern found with probe 
JG81/Pvu II on normal (10cm long) gels was shown, using 
longer (20cm) gels, to be an RFLP in which the polymorphic 
alleles were 8.5 and 8.0kb, respectively. The resolution of 
these fragment sizes on a normal gel is insufficient to allow 
accurate interpretation of the allele(s) present in any given 
individual, and the use of long gels for the analysis of this 
RFLP is necessary. The other polymorphism revealed during 
this project was for probe JG81 with the restriction enzyme 
Eco RV. The allele sizes in this case were 4.5 and 4.0kb, 
respectively, suggesting that although only tested here on 
long gels, results with this RFLP would be easily interpreted 
using normal gels.
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As mentioned above, RFLPs detected using a large number 
of DNA samples have relatively low rare allele frequencies. 
This was confirmed here, as the JG81/Pvu II and JG81/Ecp RV 
RFLPs have frequencies of 0.17 and 0.12, respectively. Given 
these values, it is unlikely that these RFLPs would be of 
great value in nondisjunction analysis. It could be argued 
that frequencies may vary in populations of different ethnic 
origin, but the 12 individuals used in the long RFLP 
screening panel came from widely varying geographic 
locations, suggesting that this possibility does not apply to 
these polymorphisms.
4.3.4 Summary of RFLP Screening
In the present study, five RFLPs were discovered with 
four of the recombinant probes tested. Only two of these have 
rare allele frequencies of greater than 0.2. The usefulness 
of one of these polymorphisms in nondisjunction analysis has 
been demonstrated.
Some of the chromosome 21 probes isolated in this 
project have not yet been screened for RFLPs, while others 
have been tested with only a limited number of restriction 
enzymes. The possibility therefore exists that additional 
polymorphisms may be detected using these chromosome 
21-specific probes. -
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4.4 Determination of Parental Origin of Nondisjunction
in Down's Syndrome Families
As mentioned in the introduction (Section 1.2.2),. 
almost all of the information to date on the parental origin 
of .nondisjunction in Down's syndrome has come from studies of 
chromosome heteromorphisms. Some of the problems inherent in 
such analysis can be overcome using RFLPs, and one of the 
aims of the current project was to use chromosome 21-linked 
RFLPs to determine the parental origin of the additional 
Chromosome 21 in Down's syndrome families.
4.4.1 Determination of Parental Origin Using 
Polymorphic DNA Markers
During the course of the current project a total of 
33 Down's syndrome families were examined using 5 chromosome 
21-specific RFLP markers, and although it was not possible to 
test each family with all 5 probes, the parental origin of 
the additional chromosome was determined in 12 families 
(36%). The majority of cases showed maternal nondisjunction 
(9 families - 75%) as opposed to paternal nondisjunction
(3 families - 25%).
Four other groups have published data on the analysis 
of nondisjunction in trisomy 21 using RFLP markers. The 
results obtained in' each of these.studies are summarised in 
Table 8, which also provides for comparison results obtained 
using cytogenetic methods. It is obvious from this table that 
the limited number of results available from RFLP studies of
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nondisjunction in trisomy 21 confirm the findings of the
numerous cytogenetic studies to date, which show that 80% of 
nondisjunction errors occur in the mother, while the
remaining 20% take place during paternal meioses.
4.4.2 Studies of Nondisjunction Using a Combination
of Cytogenetic and RFLP Techniques
Analysis of Q-banding heteromorphisms was also carried 
out during this study. Due to the constraints of time and
resources, however, only five families were tested in this 
way.. Of these, three proved to be informative and showed 
nondisjunction at the first maternal meiotic division. 
In each case the cytogenetic results were in agreement with 
those obtained using RFLPs, and in two families they provided 
information on the meiotic division responsible for the
nondisjunctional error which was not provided using RFLP 
markers alone.
Results of a similar study of trisomy 13 were recently 
published by Hassold et al. (1987), who used a combination of 
Q-banding and RFLP analysis, and in all seven cases examined 
in this way, the parental origin of the additional chromosome 
was determined (5 maternal, 2 paternal).
Cytogenetic and molecular methods have also been 
combined successfully by Stewart et al. (1988) in a pilot 
study of five Down's syndrome families. They used probes of 
16 polymorphic DNA loci from chromosome 21 in conjunction 
with Q- and NOR^ -banding techniques. This allowed the
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determination of the parental origin of the extra chromosome 
in all five cases (4 maternal, 1 paternal), in both of these 
studies, neither the cytogenetic nor the molecular methods
alone revealed the origin of the additional chromosome in
every case, and a combination of both was required to achieve 
this. It is evident from all three studies that the 
efficiency with which the origin of nondisjunction can be
determined has been greatly increased by the use of RFLP
analysis. The study of Q-banding heteromorphisms allows the 
origin of the extra chromosome 21 to be determined in 50% of 
cases; when combined with the examination of the NOR 
heteromorphisms revealed by silver staining, this figure 
rises to over 80% (Mikkelsen et al. 1980).
It is obvious that if a sufficient number of RFLP 
markers were used to examine nondisjunction in Down's 
syndrome families, the origin of the error should be found in 
every case. (A statistical consideration of this topic is 
given in Stewart et al. 1988). The studies mentioned above by 
Hcissold et al. (1987) and Stewart et al. (1988) suggest that 
a different strategy would be just as productive, since they 
have used only a fraction of the available polymorphic 
chromosome markers in conjunction with Q- and NOR-banding to 
achieve this 100% success rate.
roiiOWing
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Parental Origin of
Additional Chromosome 21
Reference Maternal Paternal
Mikkelsen et al. (1980) 61 12
Studies using Magenis & Chamberlin (1981) 151 46
cytogenetic Jongbloet et al. (1981) 51 13
markers Hatcher et al. (1982) 24 3
Ayme et al. (1986) 416 98
Total 703 172
Percentage 80% 20%
Davies et al. (1984) 1 0
Studies using Antonarakis et al. (1986) 22 3
RFLP markers Stewart et al. (1988) 4* 1
Rudd et al. (1988) 7 2
Present study (1988) 9 3
Total 43 9
Percentage 83% 17%
Table 8 : Comparison of cytogenetic and RFLP studies of 
nondisjunction in Down's syndrome families
(* - In one of the cases described by Stewart et al. (1988), RFLP 
analysis failed to reveal the parental origin of 
nondisjunction, and cytogenetic techniques provided this 
information)
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4.4.3 localisation of Nondisjunction to a Specific
Meiotic Division
Although any chromosome 21 marker can provide 
information on the parental origin of nondisjunction in 
Down's syndrome, markers for the pericentromeric region are 
essential to determine at which meiotic stage the error 
occurred. This is because recombination can occur between the 
centromere and polymorphic markers, which may lead to 
anomalous interpretation of results.
Use of markers closely linked to the centromere 
(preferably on both sides) would minimise the effects of such 
recombination. There are two types of useful pericentromeric 
marker available : (i) the cytogenetic heteromorphisms of Q- 
and NOR-banding on the short arm of chromosome 21, and (ii) 
polymorphic DNA markers which map in the proximal long arm 
(band 21qll). Although crossing-over could theoretically 
occur between the centromere and these pericentromeric 
markers, the chromosomal region involved is very small and 
"the probability of recombination taking place is low. As the 
use of cytogenetic heteromorphisms in the analysis of 
nondisjunction are discussed extensively elsewhere 
(e.g. Magenis & Chamberlin 1981), no further mention of these 
markers is made here.
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4.4.4 Polymorphic DNA Markers Close to the Centromere
The D21SI3/Tag I marker used in this project (detected 
by probe D21K9; Davies et al. 1984) is currently the most 
proximal marker on the linkage map of chromosome 21 (R.Tanzi, 
personal communication), and as such is the most useful 
marker available for the determination of the meiotic stage 
of nondisjunction in trisomy 21.
Another pericentromeric marker, D21SI10/Msp I (detected 
by probe p21-4U; D.Kurnit, personal communication) is tightly 
linked to D21S13, as shown by the fact that there were no 
recombination events between these two markers in 29 
informative meioses (R.Tanzi, personal communication). The 
combined use of these two RFLP markers allows chromosome 21 
homologues to be distinguished in a significant number of 
subjects and these markers represent a highly informative 
pericentromeric haplotype (Stewart et al. 1988).
In the study by Antonarakis et al. (1986; results also 
presented in Warren et al. 1987), the authors constructed a 
linkage map of chromosome 21 in which they favoured the 
relative order cen - D21S111 - D21S13 - (D21S1/D21S11) over 
cen - P21S13 - D21S111 - (D21S1/D21S11), and gave the
distance between D21S111 and D21S13 as 14cM. On the basis of 
this data they used the D21Slll/Sst I polymorphism
(identified by probe CW21pc) as a pericentromeric marker to 
determine the meiotic division at which nondisjunction 
occurred (details in section 4.4.5). The number of
informative meioses used in the derivation of this linkage
Page 131
order was small (Warren et al. 1987), however, and a more 
extensive study (R.Tanzi, personal communication) showed 
D21S111 to be at least 15cM distal to P21S13. The order of 
markers on 21q is therefore : cen - (D21S13/D21S110) - 15cM - 
D21S111, placing D21S111 at a substantial distance from the 
centromere. Results obtained using this RFLP marker to 
determine the meiotic stage of nondisjunction are therefore 
open to some dispute, since there is a distinct possibility 
that recombination might take place between the centromere 
and this marker.
Studies of chromosome-specific alphoid repeat sequences 
(see for example Willard et al. 1986) may provide useful 
polymorphic markers for the centromere of chromosome 21, but 
as yet no such probe has been isolated.
4.4.5 Evaluation of Results obtained using RFLP Markers 
to Determine the Meiotic Stage of Nondisjunction 
In the present study, the meiotic stage of 
' nondisjunction was defined in four families using probes 
which map distal to the q21/q22.1 junction (see Table 6 for 
details). As such, there is a significant probability that 
recombination might have occurred between the centromere and 
these RFLP markers. These results on the meiotic stage of 
nondisjunction must therefore be regarded as "provisional", 
until they can be confirmed or corrected using appropriate 
pericentromeric markers.
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In the other five cases in which the meiotic stage of 
nondisjunction was determined, this information was provided 
by the pericentromeric RFLP marker D21S13/Tag I and/or by 
analysis of cytogenetic heteromorphisms on 21p. These results 
can be considered reliable, and showed that nondisjunction 
took place at maternal meiosis I in 3 cases and at maternal 
meiosis II and paternal meiosis II, respectively, in the 
other two cases. Identical results were obtained by Stewart 
et al. (1988) in their pilot study of five families.
In the recent paper by Rudd et al. (1988), the authors 
used chromosome 21-linked RFLP markers to study the parental 
origin of nondisjunction in 20 Down's syndrome families. They 
did not attempt to determine the meiotic stage of origin, 
however, and in fact selected parental RFLP patterns in which 
it would be impossible to do so. Also, the problems caused by 
the use of D21S111 as a pericentromeric marker effectively 
nullify the results presented by Antonarakis et al. (1986) 
regarding the localisation of nondisjunction to a particular 
meiotic division. It is interesting to note that these
workers also used the D21S13/Tag I RFLP in their analysis of
Down's syndrome families, but did not think it closely linked 
to the centromere, and did not use the results obtained with 
this probe to localise nondisjunction to a specific meiotic 
division. As such, the results presented in this study 
. (for families 1-2-3, 16-17-18, 25-26-27, 28-29-30 and
31-32-33) and in that of Stewart et al. (1988) are the only
reliable results available in which RFLP and cytogenetic
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markers have been combined successfully to localise 
nondisjunction in Down's syndrome families to a specific 
meiotic division. The ratio of nondisjunction occurring at 
each meiotic division in these 10 families can therefore be 
summarised as follows :
Maternal I Maternal II Paternal I Paternal II
0 . 6 0 .2 0 0.2
These values comply almost exactly (xf = 0.13, p=0.95) with 
the maximum likelihood estimates for nondisjunction at each 
meiotic division calculated by Hassold et al. (1984), based 
on the results obtained in cytogenetic analyses :
Maternal I Maternal II Paternal I Paternal II
0.67 0.13 0.07 0.13
This demonstrates the reliability of using pericentromeric 
„ RFLP and cytogenetic markers in the localisation of 
nondisjunction to specific meiotic division in the parents of 
Down's syndrome families.
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4.4.6 Effects of Recombination on RFLP Analysis
of Nondisjunction
Crossing-over between two nondisjoined chromosomes can 
only be detected when the parent of origin is heterozygous 
for two or more markers. An example of this type of pattern 
was described previously for family 25-26-27 (Results Section 
3.4.5.). It can be stated that in this family a crossover 
event must have occurred between the markers D21S13/Tag I and 
JG77/Msp I, followed by nondisjunction at maternal meiosis I.
Stewart et al. (1988) describe similar crossover 
events in two of the five families in their pilot study. In 
one example cytogenetic markers and a polymorphic DNA marker 
on the proximal short arm of chromosome 21 are consistent 
with a maternal meiosis I error, while two more distal RFLP 
markers indicate a maternal meiosis II error. Examination of 
the band patterns for these probe/enzyme combinations 
demonstrates that nondisjunction took place at maternal 
meiosis I, and must have been preceded by a crossover between 
two of the polymorphic markers. In the other exairple, the 
converse is true, with a recombination event occurring prior 
to nondisjunction at maternal meiosis II. Recombination was 
also demonstrated in four of the seven cases of trisomy 13 
described by Hassold et al. (1987). Crossing over occurred 
prior to nondisjunction at maternal meiosis I in two cases, 
and at maternal meiosis II and paternal meiosis I in the 
other two cases. These results demonstrate that recombination 
between the centromere and RFLP markers on the long arm of
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chromosome 21 can complicate the analysis of nondisjunction 
using polymorphic DNA probes. The combination of 
pericentromeric cytogenetic and RFLP markers with polymorphic 
markers on the long arm of the chromosome should eliminate 
the confounding effects of such recombination.
4.4.7 Factors Affecting Nondisjunction - Recent Work 
1. Possible Involvement of Risosomal RNA Genes
in Nondisjunction
The ribosomal RNA gene cluster on chromosome 21 
(RNR4) is located in the secondary constriction, or "stalk" 
region, in band 21pl2. These secondary constrictions 
associated with cell nucleoli are called nucleolar organising 
regions (NORs). A recent study of the inheritance of NOR 
variants (visible after silver staining) in trisomy 21 
families suggested that a particular type of heteromorphism, 
called a double NOR (dNOR) may play a role in meiotic 
nondisjunction (Jackson-Cook et al. 1985). To date, however, 
no other group (e.g. Spinner et al. 1986, Hassold et al. 
1988) has been able to confirm- a high frequency of dNOR 
variants in Down's syndrome subjects and families.
Also, the tendency of ribosomal genes to undergo 
non-homologous recombination has been proposed as a possible 
mechanism, via the formation of dicentric chromosomes, for 
promoting meiotic nondisjunction (Schmickel et al. 1985).
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2. Possible Effects,of Aberrant Recombination
Levels on Nondisjunction
As mentioned in the Introduction (Section 1.2.5),
aberrant levels of recombination have been proposed as a
possible factor influencing the normal segregation of
chromosomes at meiosis. Use of the centromere mapping
technique (Ott et al 1976) allows the possible effects of
aberrant levels of recombination on nondisjunction in Down's
syndrome to be evaluated by estimating the levels of
recombination on chromosomes 21 involved in normal meioses 
with those undergoing nondisjunction.
This approach was used recently by Antonarakis et al. 
(1986), in a study of 34 Down's syndrome families, their 
parents and normal sibs. They reported statistically
significant reductions in the map distances associated with 
trisomy 21 and stated that recombination involving the two
nondisjoined chromosomes was rarely detected. From these 
results it was suggested that recombination is reduced on
chromosome 21s that undergo nondisjunction and that defective 
pairing may consequently be responsible for a large
proportion of cases of trisomy 21.
Apart from small sample size, there are some technical 
limitations to this study, however. Firstly, they used 
markers that did not span the terminal third of chromosome 
21. Since the linkage map of chromosome 21 (R.Tanzi, personal 
communication) shows a high frequency of terminal chiasmata 
on 21q, markers from this part of the chromosome should also
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be included in any such study. Secondly, they used D21S111 as
a pericentromeric marker and, as described previously
(Section 4.4.4) this locus is at a substantial distance from
the centromere, and as such is not the ideal choice for
determination of the meiotic stage of nondisjunction.
The results presented in the present study, and by
other workers (Hassold et al. 1987, Stewart et al. 1988),
demonstrating recombination between nondisjoined chromosomes
*
in a significant proportion (44% ) of cases suggest that 
pairing failure is not the only cause of autosomal trisomy. 
In order to fully investigate the possible relevance of 
aberrant recombination levels on nondisjunction, a large 
sample size should be studied using both pericentromeric 
cytogenetic and RFLP markers in conjunction with RFLP markers 
spanning the whole length of the long arm of chromosome 21.
*
( - As mentioned above (Section 4.4.6), crossing-over
between two nondisjoined chromosomes can only be detected 
when the parent of origin is heterozygous for two or more 
markers. Only cases in which these conditions are satisfied 
are included in the calculation of this figure. Details as 
follows : Present Study - 1 out of 5 cases; Stewart et al.
(1988) - 2 out of 5 cases; Hassold et al. (1987) - 4 out of 6 
cases)
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4.5 Genes Mapped to Chromosome 21 - Recent Work
As with other human chromosomes, recent advances in 
molecular genetic techniques, particularly in the field of 
somatic cell genetics, have led to the assignment of 
additional genes to chromosome 21 and to the more accurate 
localisation of genes previously mapped to this chromosome 
(for details see HGM 9, 1988). The number of anonymous DNA 
sequences localised to chromosome 21 has also increased 
enormously : from 9 at the beginning of this project to the 
present total of 99 (see In fact, this number does
not include the 13 single-copy chromosome 21-specific DNA 
sequences isolated during the present study. These therefore 
represent almost 12% of the arbitrary DNA sequences so far 
mapped to this chromosome, and as such . are a major 
contribution to the molecular map of chromosome 21.
The regional localisation of polymorphic DNA probes on 
chromosome 21 and their incorporation into genetic linkage 
maps of the chromosome has shown that the physical and 
genetic maps of chromosome 21 are in close agreement (see, 
for exanple, Watkins et al. 1987).
Some of the most exciting recent developments in the 
molecular analysis of chromosome 21 concerned the 
localisation to this chromosome of genes involved in 
Alzheimer's disease; these are summarised in section 4.5.1. 
The possible relevance of the DNA probes isolated in the 
present study to Down's syndrome and Alzheimer's disease is 
considered in section 4.5.2.
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4.5.1 Recent Developments in the Study of the Molecular 
Biology of, Alzheimer's Disease
Alzheimer's disease (AD) is a progressive neuro- 
degenerative disorder characterised by widespread functional 
disturbance of the human brain. The fact that almost all 
Down's syndrome patients over the age of 40 display this 
characteristic neuropathology (Wisniewski et al 1985) 
suggested a possible link between the two disorders. This 
theory is supported by recent developments in the study of AD 
at the molecular level, as follows.
1._____ Localisation of the Amyloid Plaque Protein (A4)
to Chromosome 21
A major structural component of the neuritic plaques 
found in the brain of AD patients is a substance called 
amyloid. The major subunit of this is an insoluble highly 
aggregating small polypeptide called amyloid beta protein A4. 
Three different groups of researchers used synthetic oligo­
nucleotides deduced from the sequence of the A4 polypeptide 
to isolate cDNA clones encoding the complete A4 subunit 
protein from foetal brain cDNA libraries (Goldgaber et al. 
1987, Kang et al. 1987, Tanzi et al. 1987a). All three groups 
mapped the amyloid beta peptide (AP) gene to chromosome 21 
using somatic cell hybrids, while Tanzi et al. (1987a) 
regionally localised the gene to 21qll.2 - 21q21.
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2 ._____ Localisation of the Gene for Familial Alzheimer's
Disease (FAD) to Chromosome 21
Several large families have been reported in which 
autosomal dominant transmission of AD is apparent (Nee et al. 
1983, Goudsmit et al. 1981). Given the suggested link between 
AD and Down's syndrome and the availability of numerous 
polymorphic DNA markers on chromosome 21, one group of 
researchers decided to test for co-segregation of the gene 
for FAD and several anonymous chromosome 21 DNA markers
(St George-Hyslop et al. 1987a). Positive LOD scores were 
obtained for linkage of FAD with the DNA markers D21S16 
(z =2.32 at 0 = 0.00) and D21S1/D21S11 (z = 2.37 at
0 = 0.08), which map in the region 21qll.2 - 21q21. The LOD 
scores for neither probe were greater than three, however, 
and could not by themselves be considered as proof of 
linkage. Conclusive evidence of the localisation of the FAD 
gene to chromosome 21 was provided by three point analysis of 
FAD, D21S16 and D21S1/D21S11, which provided a peak LOD score 
of 4.25. Testing of additional DNA markers from this region 
on these and other FAD pedigrees should allow a more accurate 
location for the FAD gene to be defined.
3. Does Duplication of Chromosome 21 Genes
Cause Alzheimer's Disease?
One group of workers claimed to have shown that the AP 
gene is duplicated in patients with Alzheimer's disease 
(Delabar et al. 1987) and suggested that the neuro-
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pathological changes observed in aged Down's syndrome 
individuals might be caused by over-expression of the amyloid 
beta peptide (AP) gene due to the presence of the extra copy 
of chromosome 21 in these patients. Recent reports have 
shown no evidence of duplication of chromosome 21 genes in 
individuals with Alzheimer's disease (St George-Hyslop et al. 
1987b, Tanzi et al. 1987c, Podlisny et al. 1987) and suggest 
that the results obtained by Delabar et al. (1987) are an 
artifact of the experimental methods used. It would appear, 
therefore, that duplications in the AP gene, the FAD gene or 
the Down's syndrome critical region (all of which were tested 
by St George-Hyslop et al. 1987b) are not common events in 
either sporadic or familial Alzheimer's disease.
_4.______Is the Amyloid Beta Protein Gene the Source of the
Genetic Defect in Familial Alzheimer's Disease?
Mapping of the genes for AP and FAD into the 
qll.2 - q21 region of chromosome 21 raised the possibility 
that the AP gene might represent the primary genetic defect 
in Alzheimer's disease. However, two independant groups of 
researchers, using frequent RFLPs of the A4-amyloid gene to 
study large FAD pedigrees, found recombination between the 
Alzheimer's disease locus and the AP gene on several 
occasions (Tanzi et al. 1987b, Van Broeckhoven et al. 1987). 
The former group excluded the FAD gene from a region of
/T
approximately 8 x 10 bp of DNA on either side of the AP 
locus. This demonstration of non-linkage between FAD and the
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AP gene suggests that alterations in the AP gene are not the 
primary defect causing Alzheimer's disease.
4.5.2 Relevance of Probes Isolated During the Current Study 
to Down's Syndrome and Alzheimer's disease
1. Down's syndrome
As mentioned previously (Introduction, Section 1.1.3), 
there is a lack of agreement over the definition of the 
critical region of chromosome 21 involved in Down's syndrome. 
Most workers agree that bands 21q22.1 and 21q22.2 are 
necessary to develop the Down's syndrome phenotype, but other 
groups suggest that band 21q22.3 should also be included in 
the pathogenic segment. It can be seen from Table 3 and 
Figure 15 that six of the single-copy probes isolated in the 
current project map into the 21q22.1 - 21qter region (JG12, 
JG22, JG24, JG63, JG81 and JG108), and one (probe JG77) to
the region 21q22.1 -21q22.2. These chromosome 21-specific DNA 
sequences m y  therefore be involved in the pathogenesis of 
Dowrf's syndrome. Probe JG77 is of further interest because it 
was shown to be expressed in Northern blot experiments 
(Results, Section 3.5). This raises the possibility that this 
sequence might represent part of a gene involved in the 
pathogenesis of Down's syndrome.
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2. Alzheimer's disease
localisation of the genes for familial Alzheimer's 
disease (FAD) and amyloid beta protein (AP) to the 21qll.2 - 
21q21 region confirmed what scientists had suspected for some 
time - that a connection existed between Down's syndrome and 
Alzheimer's disease. This finding is of particular importance 
to the present study, as any DNA markers assigned to this 
chromosomal region might be linked to, or might even 
represent part of either of these genes. It should be noted, 
however, that this chromosomal region is large enough to 
contain around 500 genes (Barnes 1987), and presumably a 
large number of DNA markers localised to this region of 
chromosome 21 will not show linkage to either gene.
A further cause for optimism, however, is provided by 
the relatively new technologies of "walking" (Steinmetz 
et al. 1984) and "jumping" (Collins & Weissman 1984, Poustka 
et al. 1987) the chromosome. As mentioned in the Introduction 
(Section 1.4), these techniques allow the use of DNA 
sequences not closely linked to an original clone for the 
isolation of genes and/or sequences important in the 
pathogenesis of inherited disorders. Application of these 
methods to the study of Alzheimer's disease could therefore 
allow the primary genetic defect involved to be identified 
using DNA probes mapped to the 21qll.2 - 21q21 region.
Five of the single-copy probes isolated during the 
current study map into this chromosomal region (JG21, JG62, 
JG72, JG90 and JG99), and it is possible that these sequences
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might either be directly involved in the pathogenesis of 
Alzheimer's disease, or may lead to the isolation of 
sequences important in the disorder. In fact, the JG90/Nde II 
marker is currently being tested for possible linkage with 
either the AP gene or the gene for familial Alzheimer's 
disease (A.Vandenberghe, personal communication).
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4.6 Conclusions
Although the chromosomal abnormality for Down's 
syndrome has been known for over 25 years the biochemical and 
molecular basis for the expression of the phenotype is still 
poorly understood. It has been shown that the q22 region of 
chromosome 21 is responsible for the Down's syndrome 
phenotype. The isolation of DNA probes from this part of the 
chromosome, as described in the current project, provides a 
possible means of investigating the molecular pathogenesis of 
Down's syndrome by defining the number of genes involved, 
their function and temporal expression during development.
The most important applications of arbitrary DNA 
sequences relate to their ability to detect restriction 
fragment length polymorphisms (RFLPs). Polymorphic DNA probes 
from chromosome 21 have three important uses : (i) to follow 
the inheritance of chromosome 21 in Down's syndrome families, 
and in this way permit the parental origin, and in some cases 
the meiotic stage, of nondisjunction to be defined; (ii) to 
show linkage with genetic disorders of unknown chromosomal 
origin, as recently demonstrated in the localisation of 
familial Alzheimer's disease to chromosome 21; (iii) in the 
construction of a genetic linkage map of chromosome 21. This 
last objective, in conjunction with the construction of 
similar linkage maps of all other human chromosomes, has the 
ultimate aim of allowing any genetic disease loci to be 
mapped to a particular chromosome by virtue of linkage with 
arbitrary polymorphic DNA markers.
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The combination of regional mapping of DNA sequences 
using somatic cell hybrids with the recently developed 
technique of pulse field electrophoresis allows the 
construction of a detailed physical map of huamn chromosomes. 
Several laboratories have in fact already begun such research 
programs, and it has been predicted that future research may 
eventually result in the sequencing of the entire human 
genome, which should provide the answers to numerous 
currently intractable questions in the field of human 
genetics.
In the absence of an understanding of the molecular 
pathogenesis of Down's syndrome, no rational therapy is 
available, and current emphasis must therefore lie with 
prevention of the disorder. Lack of knowledge about the 
mechanisms involved in nondisjunction means that secondary 
prevention by detection and selective termination of 
pregnancy is currently the main focus of effort. To 
facilitate this the identification of risk factors for Down's 
syndrome such as increased maternal age and reduced levels of 
maternal serum alpha-fetoprotein is clearly important.
Polymorphic DNA probes as described in this study might 
also be of use in the definition of risk factors in families 
showing recurrent trisomy 21 - by comparing pericentromeric 
RFLP haplotypes in affected family members it could be 
determined whether or not all centromeres are equally 
predisposed to nondisjunction. Furthermore, DNA probes may 
also be useful for diagnosis of Down's syndrome either by
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in situ hybridisation to interphase nuclei or by dosage 
studies in fetal tissues, which might be obtained either by 
conventional prenatal diagnosis techniques or by isolation of 
fetal cells from maternal blood.
To summarise, the results obtained in this project 
represent a valuable contribution to the molecular analysis 
of chromosome 21 and Down's syndrome, and should prove useful 
in future research into many different aspects of the 
molecular biology of chromosome 21-linked disorders.
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